Endocrine Abstracts

Contents

• 22nd European Congress of Endocrinology
• • Prize Lectures and Biographical Notes
  • The Geoffrey Harris Prize Lecture
  • • Abstract unavailable

      ea0070ap1
    • ESE Geoffrey Harris Prize 2020 – Biography

      ea0070ap1biog
  • The European Journal of Endocrinology Prize Lecture
  • • Shining light on membrane receptors

      ea0070ap2
    • EJE Award 2020 – Biography

      ea0070ap2biog
  • European Hormone Medal Lecture
  • • The cause of autoimmune endocrine diseases

      ea0070ap3
    • European Hormone Medal 2020 – Biography

      ea0070ap3biog
  • Clinical Endocrinology Trust Lecture
  • • Postmenopausal osteoporosis: balancing the risks and benefits

      ea0070ap4
    • Clinical Endocrinology Trust Award 2020 – Biography

      ea0070ap4biog
• Plenary Lectures
• • Exercise as medicine - a translational perspective
  • • Abstract unavailable

      ea0070pl1
  • Glucocorticoids in cancer: a new paradigm
  • • Abstract unavailable

      ea0070pl2
  • Harnessing the microbiome in metabolic disease
  • • Harnessing the microbiome in metabolic disease

      ea0070pl3
  • Mechanisms for SARS-CoV-2 cell entry
  • • SARS-CoV-2 entry into cells and its inhibition

      ea0070pl4
  • Maternal thyroid hormone and child brain development
  • • Abstract unavailable

      ea0070pl5
  • It takes thyroid hormone to make sense
  • • Maternal thyroid hormone and child brain development

      ea0070pl6
  • Effects of EDCs on neuro-endocrine systems and behaviour
  • • Endocrine disruption of neuroendocrine development, function, and behavior

      ea0070pl7
• Symposia
• • New horizons in phaeochromocytoma and paraganglioma
  • • Abstract unavailable

      ea0070s1.1
    • Combination targeted therapies for malignant tumours – towards precision medicine

      ea0070s1.2
    • Abstract unavailable

      ea0070s1.3
  • Osteoporosis and fracture prediction
  • • Risk of fractures following discontinuation of denosumab – and how to handle it

      ea0070s2.1
    • Abstract unavailable

      ea0070s2.2
    • The role of bone turnover markers in the diagnosis and management of osteoporosis

      ea0070s2.3
  • Controversial issues in bariatric surgery
  • • Abstract unavailable

      ea0070s3.1
    • Abstract unavailable

      ea0070s3.2
    • Relapse and prediction of relapse

      ea0070s3.3
  • Unveiling signatures in pituitary neuroendocrine tumours
  • • Circulating microRNAs: from PitNET pathogenesis to diagnostics

      ea0070s4.1
    • Abstract unavailable

      ea0070s4.2
    • Unravelling the PitNET methyloma

      ea0070s4.3
  • Hyperthyroidism across the lifespan
  • • Hyperthyroidism in pregnancy

      ea0070s5.1
    • Abstract unavailable

      ea0070s5.2
    • Hyperthyroidism in adolescents

      ea0070s5.3
  • Adrenocortical carcinoma
  • • Tumor tissue micro-environment in adrenal tumor

      ea0070s6.1
    • Circulating microRNAs in the differential diagnosis of benign and malignant adrenocortical tumours

      ea0070s6.2
    • ACC - what’s new today; where is hope tomorrow

      ea0070s6.3
  • Endocrine disruptors, just a hype or not?
  • • The environment and male fertility, will we disappear?

      ea0070s7.1
    • The bad cocktail of endocrine disruptors

      ea0070s7.2
    • Micro(nano) plastics, a real threat or not?

      ea0070s7.3
  • PCOS: from Genetics to Treatment
  • • Abstract unavailable

      ea0070s8.1
    • Estroprogestins and female sexuality

      ea0070s8.2
    • Current insights into the genetics of polycystic ovary syndrome

      ea0070s8.3
• Covid-19 Session
• • Endocrine targets related to COVID infection
  • • Endocrine targets related to COVID19 infection

      ea0070cs1.1
  • Managing the Cytokine storm
  • • Abstract unavailable

      ea0070cs1.2
  • How strong is obesity as a risk factor for COVID-19 patients
  • • How strong is obesity as a risk factor for COVID-19 patients?

      ea0070cs1.3
• Oral Communications
• • Adrenal and Cardiovascular Endocrinology
  • • Inhibition of glutaminases as a potential novel treatment for SDHB-associated pheochromocytomas/paragangliomas

      ea0070oc1.1
    • A Phase III randomized, controlled trial of a modified-release hydrocortisone formulation in the treatment of classic congenital adrenal hyperplasia

      ea0070oc1.2
    • Tumor microenvironment adipose stem cells modulate adrenocortical carcinoma progression

      ea0070oc1.3
    • Immune infiltrate and PD-1 / PD-L1 expression in adrenocortical carcinoma: who can predict patients´ outcome?

      ea0070oc1.4
    • The utility of salivary cortisol and cortisone measurement in the assessment of cortisol secretion in adrenal incidentalomas

      ea0070oc1.5
    • Modified GRAS score for prognostic classification of adrenocortical carcinoma: an ENSAT multicentre study

      ea0070oc1.6
    • Comparative proteomic analysis of different bilateral adrenocortical hyperplasia

      ea0070oc1.7
  • Bone and Calcium
  • • Real-life clinical study: 1-year of treatment with burosumab of children and adolescents affected with X-linked hypophosphatemia

      ea0070oc2.1
    • STOPFOP: A european phase II clinical trial using saracatinib to prevent FOP

      ea0070oc2.2
    • Prediction algorithm for persistent primary hyperparathyroidism after parathyroidectomy

      ea0070oc2.3
    • Loss of glucocorticoid rhythm induces an osteoporotic phenotype in mice

      ea0070oc2.4
    • Effect of nine months of vitamin D supplementation on areal and volumetric bone mass density and bone architecture in graves’ disease: a double-blinded, randomized clinical trial

      ea0070oc2.5
    • Superior efficacy of calcifediol soft gelatin capsules vs cholecalciferol independently of bmi, for the management of vitamin d deficiency in postmenopausal women: a treatment to be considered in therapeutic guidelines

      ea0070oc2.6
    • Surgery alone or surgery in combination with postoperative zoledronic acid for the treatment of osteoporosis in primary hyperparathyroidism: a 2-year double-blind randomized placebo-controlled study

      ea0070oc2.7
  • Diabetes, Obesity, Metabolism and Nutrition
  • • Twenty-two years results of the israeli-georgian program diabetes in pregnancy

      ea0070oc3.1
    • Influence of obesity in the miRNome landscape: miR-4454, a tissue-specific regulator of insulin response

      ea0070oc3.2
    • Circulating follistatin predicts type 2 diabetes risk

      ea0070oc3.3
    • Dietary intake of fat and oil are associated with expression of miR-143 and miR-34a in visceral and subcutaneous adipose tissues: A nutriepigenetic study

      ea0070oc3.4
    • Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial

      ea0070oc3.5
    • 11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: A randomized, double-blind, placebo-controlled trial

      ea0070oc3.6
    • Efficacy and safety of volanesorsen for the treatment of metabolic complications in patients with familial partial lipodystrophy: results of the BROADEN study

      ea0070oc3.7
  • Pituitary and Neuroendocrinology
  • • Quantitative mRNA expression of PROK2, DUSP6, and WDR11 in peripheral blood as diagnostic criteria for central hypogonadism

      ea0070oc4.1
    • Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging mice

      ea0070oc4.2
    • Clinical implications of Pan-genomic classification of pituitary neuroendocrine tumours

      ea0070oc4.3
    • Thyrotropin/Thyrotropin receptor signaling deficiency impairs spatial learning and memory

      ea0070oc4.4
    • Durability of response and gender-based analysis from the LINC3 trial of osilodrostat in the treatment in cushing’s disease

      ea0070oc4.5
    • Results from the phase 3, randomized, double-blind, placebo-controlled OPTIMAL study of oral octreotide capsules in adult patients with acromegaly

      ea0070oc4.6
    • Fluid restriction results in a modest rise in plasma sodium concentration in chronic hyponatraemia due to SIAD; results of a prospective randomised controlled trial

      ea0070oc4.7
  • Thyroid
  • • TSH-Independent upregulation of thyroid-specific gene expression in dehal1 knockout mice

      ea0070oc5.1
    • Overtreatment of papillary thyroid microcarcinoma: a snapshot from the italian thyroid cancer observatory

      ea0070oc5.2
    • Acute pancreatitis associated with methimazole treatment: A retrospective analysis of administrative health databases conducted in the Piedmont Region, Italy

      ea0070oc5.3
    • Drug repurposing identifies inhibitors of the proteostasis network to augment radioiodine uptake in combinatorial approaches targeting thyroid cancer

      ea0070oc5.4
    • Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free-survival and overall survival in non-small cell lung cancer: an original cohort study

      ea0070oc5.5
    • Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections

      ea0070oc5.6
    • Triiodothyronine (T3) use in hypothyroidism and effects on cancer and mortality

      ea0070oc5.7
  • Hot Topics (including COVID-19
  • • Effects of nonpeptide orally bioavailable ACTH antagonists on adrenal gland size and function in rats

      ea0070oc6.1
    • Experimental induced autoimmune thyroiditis in wistar rats: possible protective role of selenium

      ea0070oc6.2
    • Expression of estrogen-related receptors and epidermal growth factor receptor in normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

      ea0070oc6.3
    • High-dose Vitamin D supplementation reduces inflammation and improves microcirculation in patients with diabetic peripheral neuropathy – a randomized control trial

      ea0070oc6.4
    • TransCon PTH, a long-acting PTH, in patients with hypoparathyroidism: Results of the phase 2 PaTH forward trial

      ea0070oc6.5
    • Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity

      ea0070oc6.6
    • Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

      ea0070oc6.7
  • Endocrine-related Cancer
  • • Is Carney complex a breast cancer predisposing syndrome? prospective study of 50 women

      ea0070oc7.1
    • The role of the tumour microenvironment in pituitary adenoma angiogenesis

      ea0070oc7.2
    • Sterol O-Acyl transferase 1 as a prognostic marker of adrenocortical carcinoma

      ea0070oc7.3
    • Increased E2F1 mRNA and miR-17-5p expression may predict aggressiveness of pituitary neuroendocrine tumours

      ea0070oc7.4
    • Differential adrenal toxicity of SOAT1-inhibitors

      ea0070oc7.5
    • Llaser ablation vs radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomised, parallel, open-label, trial (LARA trial)

      ea0070oc7.6
    • A rare case of lynch syndrome in a patient with metastatic malignant paraganglioma with SDHA mutation

      ea0070oc7.7
  • Environmental Endocrinology
  • • The mosaic effects of endocrine disrupting chemicals mixtures on thyroid hormone levels: experimental study

      ea0070oc8.1
    • Air pollution and incidence of hypertension in spanish adults [email protected] study

      ea0070oc8.2
    • Comparative histopathology of endocrine glands in phthalate exposed male Wistar rats unveil the vulnerability of adrenal gland and augmented by molecular docking

      ea0070oc8.3
    • Cigarette smoking and the risk to develop symptoms of Hashimoto’s thyroiditis

      ea0070oc8.4
    • Effects of perinatal exposure to triclosan on neuronal development and behavior of mice

      ea0070oc8.5
    • Temporal and spatial trends of operated cryptorchidism in France and environmental hypotheses: a nationwide study from 2002 to 2014

      ea0070oc8.6
  • Reproductive and Developmental Endocrinology
  • • Identification of a novel hypothalamic miRNA/Kisspeptin pathway as pathophysiological mechanism and putative target for management of obesity-induced hypogonadism

      ea0070oc9.1
    • Kisspeptin as a biomarker for pregnancy complications

      ea0070oc9.2
    • Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients

      ea0070oc9.3
    • Demonstration of follicle-stimulating hormone receptor and G protein-coupled estrogen receptor heteromers in vitro via BRET and super-resolution imaging

      ea0070oc9.4
    • Genetic dissection of spermatogenic arrest through whole exome analysis: Clinical implications for the management of azoospermic men

      ea0070oc9.5
    • Testosterone replacement therapy of opioid induced male hypogonadism improved body composition but not pain perception A double-blinded, randomized and placebo-controlled trial

      ea0070oc9.6
    • Abstract unavailable

      ea0070oc9.7
  • Young Investigators
  • • A mixed nutrient preload attenuates glucose-induced endothelial dysfunction in individuals with abnormal glucose tolerance

      ea0070yi1
    • Transcriptomic response of mouse thyroid to iodine by upregulating Nrf2-dependent and independent pathways

      ea0070yi2
    • RNA-sequencing of adrenocortical tumors reveals novel pathogenetic insights

      ea0070yi3
    • Evidence for increased SSTR5 expression and improved pasireotide response in USP8 mutant corticotroph tumours

      ea0070yi4
    • Splicing machinery is dysregulated in craniopharyngiomas: a novel source of diagnostic, prognostic and therapeutic biomarkers

      ea0070yi5
    • Dysregulation of splicing factor 3B SUBUNIT 1 (SF3B1) is associated with the pathological transformation of the liver: Pharmacological inhibition with pladienolide-B as novel therapeutic tool in liver disease

      ea0070yi6
    • Congenital isolated follicle-stimulating hormone deficiency due to the FSHB gene mutation in a female patient – a rare case report

      ea0070yi7
    • Towards the development of an in vitro 3D human thyroid model

      ea0070yi8
    • Comparison between the efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: an interim analysis

      ea0070yi9
    • Association of dietary and plasma fatty acids with adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) gene expression in human adipose tissues

      ea0070yi10
    • Growth hormone-releasing hormone (GHRH) antagonists increase the sensitivity to radiotherapy in lung cancer cells

      ea0070yi11
    • Identification of transcriptome profiles in paraffin samples using 3’ RNA-sequencing for the prognostic assessment of adrenocortical carcinoma

      ea0070yi12
• Audio ePoster Presentations
• • Adrenal and Cardiovascular Endocrinology
  • • Residual corticosteroid production in autoimmune addison´s disease

      ea0070aep1
    • Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?

      ea0070aep2
    • Is there an epithelial to mesenchymal transition (EMT) in adrenocortical tumours?

      ea0070aep3
    • Copy number determination of steroid 21-hydroxylase gene for the genetic testing of congenital adrenal hyperplasia using real-time quantitative PCR

      ea0070aep4
    • Cytochrome P450 (CYP) 2W1 affect steroid secretion in adrenocortical cell line and tumor tissues

      ea0070aep5
    • Integrated genomics reveals different subgroups of primary bilateral macronodular adrenal hyperplasia (PBMAH)

      ea0070aep6
    • Investigation of angiotensin II induced gene expression changes in vascular smooth muscle cells

      ea0070aep7
    • Structural instability of mutant variants of 21-Hydroxylase

      ea0070aep8
    • Persistent transcriptional disruption and histone mark modifications on visceral adipose tissue after remission of hypercortisolism

      ea0070aep9
    • Cortisol rhythm in patients with adrenal insufficiency switched from conventional glucocorticoids to dual release hydrocortisone: Impact on metabolic profile

      ea0070aep10
    • Adrenal cortex is responsive to human chorionic gonadotropin stimulation in patients with adrenal incidentalomas

      ea0070aep11
    • Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients.

      ea0070aep12
    • Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: A long-term retrospective study

      ea0070aep13
    • Comparability of steroid hormone measurement among 9 European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS): Impact of the blood derivative and of calibration

      ea0070aep14
    • Multiple hormonal deficiency in heart failure with preserved ejection fraction: Prevalence and role in modulation of antioxidant levels and myocardial dysfunction indexes

      ea0070aep15
    • Effects of adrenalectomy on arterial hypertension in patients with adrenal subclinical hypercortisolism: Preliminary results of a randomized clinical trial

      ea0070aep16
    • A double-blind, randomized, placebo-controlled phase 3 study to assess the efficacy and safety of relacorilant, a selective glucocorticoid receptor modulator, in patients with hypercortisolism due to cortisol-secreting adrenal adenoma(s)/hyperplasia

      ea0070aep17
    • Aetiology, clinical presentation and mortality of Addison’s disease in India: A retrospective follow-up study over 14 years

      ea0070aep18
    • Genes mediating cell growth in aldosterone-producing adenomas

      ea0070aep19
    • Transcriptomic profiling of canine adrenocortical tumors

      ea0070aep20
    • Psychosocial determinants of body acceptance and quality of life in women with congenital adrenal hyperplasia

      ea0070aep21
    • The study of cell senescence in cortisol-producing adrenocortical adenoma

      ea0070aep22
    • Mortality in patients with adrenal incidentalomas and autonomous cortisol secretion

      ea0070aep23
    • Real life experience of 8 people with adrenal insufficiency using subcutaneous hydrocortisone infusion in continuous and pulsatile regimens recruited through hydrocortisone pump support group

      ea0070aep24
    • The glucocorticoid receptor in macrophages protects against inulin resistance and promotes homeothermy

      ea0070aep25
    • Genetic alterations and clinical features in 16 brazilian patients with pheochromocytomas and paragangliomas

      ea0070aep26
    • Peritoneal implantation of pheochromocytoma – two cases of pheochromocytomatosis

      ea0070aep27
    • The role of cytotoxic chemotherapy in adjuvant treatment of radically resected adrenocortical carcinoma

      ea0070aep28
    • Treatment outcomes in 198 patients of the portuguese adrenocortical carcinoma register

      ea0070aep29
    • Excess glucocorticoid activity may suppress tumor immune activity in adrenocortical carcinoma

      ea0070aep30
    • Functional ectopic adrenocortical carcinoma; A case report

      ea0070aep31
    • A rare case of functioning adrenocortical oncocytoma of uncertain malignant potential in a young female diagnosed with type 1 neurofibromatosis

      ea0070aep32
    • Adrenocortical cancer mimicking lymphoma on magnetic resonance scan

      ea0070aep33
    • Cushing’s syndrome during pregnancy - case presentation and follow-up.

      ea0070aep34
    • A rare presentation of salt wasting in congenital adrenal hyperplasia with 11β-hydroxylase deficiency.

      ea0070aep35
    • Identification of the genetic signature of vascular calcification in patients with type 2 diabetes mellitus by a computational approach

      ea0070aep36
    • Physiologically based pharmacokinetic modelling to inform dosing in adrenal insufficiency and congenital adrenal hyperplasia

      ea0070aep37
    • An unusual case of Cushing’s syndrome secondary to ACTH producing prostate adenocarcinoma

      ea0070aep38
    • Effects of endogenous hypercortisolism on selected Angio-miRs expression in humans

      ea0070aep39
    • Association of the subclinical hypercorticism and BclI glucocorticoid receptor polymorphism with bone mineral density in women with adrenal incidentalomas

      ea0070aep40
    • Somatostatin receptors 2A and 5 expression in adrenocortical cancer

      ea0070aep41
    • Prognostic value of Ki-67 and ENSAT stage on recurrence-free survival and overall survival in patients with adrenocortical carcinoma

      ea0070aep42
    • CYP11B2 DNA methylation pattern is discordant in aldosterone-producing adenomas and in concurrent aldosterone-producing cell clusters

      ea0070aep43
    • Etiology and extent of impaired quality of life, fatigue and affective, cognitive, and emotional dysfunction in patients with cushing’s syndrome – The IQFACE-CS study

      ea0070aep44
    • Regression of the adrenal X-zone controlled by JAK pathway in SF1/SOCS3 KO mice

      ea0070aep45
    • Fertility testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0070aep46
    • Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas

      ea0070aep47
    • Early renin recovery after adrenalectomy in patients with aldosterone-producing adenoma - a longitudinal study.

      ea0070aep48
    • Comparison of incidence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma across different BMI and age distribution

      ea0070aep49
    • Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension

      ea0070aep50
    • Isolated acquired hypoaldosteronism as a cause of hypovolemic hyponatremia with urinary sodium loss

      ea0070aep51
    • Ambulance alert system enabling pre-hospital parenteral steroids for patients with adrenal insufficiency

      ea0070aep52
    • Trends in the incidence of adrenal incidentaloma diagnosed by CT abdomen in 2002 and 2015: Preliminary data from a retrospective study in regional sweden

      ea0070aep53
    • Sympathoadrenal system function in patients with multiple sclerosis

      ea0070aep54
    • Steroidogenic proteins expression pattern in adrenocortical carcinomas

      ea0070aep55
    • Crinecerfont (NBI-74788), a novel CRF1 receptor antagonist, reduces adrenal androgens and precursors in patients with classic congenital adrenal hyperplasia: Results from a phase 2, multiple-dose study

      ea0070aep56
    • Possible protective influence of KCNJ5 and CACNA1D gene polymorphisms on lipid profile in primary aldosteronism and essential hypertensive patients

      ea0070aep57
    • Steroid hormones influence systemic sclerosis prevalence

      ea0070aep58
    • Algorithm of staged perioperative hemodynamic management (SPOHM)

      ea0070aep59
    • 16 year-old woman with abdominal paraganglioma secondary to SDHB mutation

      ea0070aep60
    • Pheochromocytoma multisystem crisis presenting with cardiogenic shock and Tako-tsubo cardiomyopathy.

      ea0070aep61
    • Reducing short synacthen tests by deriving a novel baseline and 30 min cortisol level for a scottish population

      ea0070aep62
    • Surgical outcomes of adrenalectomy for primary hyperaldosteronism after using novel diagnostic tests

      ea0070aep63
    • Subtyping of primary aldosteronism in patients with partially successful adrenal vein sampling

      ea0070aep64
    • Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia

      ea0070aep65
    • Indications for aldosterone/renin screening presented by patients later diagnosed with hyperaldosteronism in a general endocrinology outpatient clinic

      ea0070aep66
    • Hyperparathyroidism in patients with overt and mild primary aldosteronism: Epidemiological data from a tertiary centre

      ea0070aep67
    • Does adrenal vein sampling really improve the final approach for treating prymary aldosteronism? a retrospective study.

      ea0070aep68
    • Pulsatile subcutaneous hydrocortisone replacement in primary adrenal failure, a proof of concept pilot trial

      ea0070aep69
    • CAH-X Syndrome in a german cohort of patients with 21--hydroxylase deficiency

      ea0070aep70
    • Cardiovascular risk and metabolic profile in adult patients with congenital adrenal hyperplasia

      ea0070aep71
    • Adrenal incidentalomas and renal cysts – the definitive sign of aging?

      ea0070aep72
    • Major barriers exist in the diagnosis and management of addison’s disease in africa

      ea0070aep73
    • Acute adrenal failure as presenting feature of antiphospholipid syndrome

      ea0070aep74
    • Differential diagnosis of primary adrenal insufficiency in a young male with mental retardation and axonal sensorimotor polyneuropathy

      ea0070aep75
    • Bronchogenic cyst mimicking adrenal mass

      ea0070aep76
    • Primary aldosteronism : Study of 09 cases

      ea0070aep77
    • Adrenal necrosis caused by streptococcus constellatus infection

      ea0070aep78
    • Endothelial vascular adrenal cyst with unusual presentation

      ea0070aep79
    • Less common form of adult secondary hypertension

      ea0070aep80
    • Behavior of adrenal incidentalomas with density computed tomography scan > 10 HU

      ea0070aep81
    • Malignant collision tumour in left adrenal gland- A rare tumour

      ea0070aep82
    • JIL-O: Establishment of a new steroidogenic human adrenocortical carcinoma cell line

      ea0070aep83
    • Prognostic factors and overall survival in patients with adrenocortical cancer: Experiences of a single tertiary referral endocrine centre in Hungary (1974–2019)

      ea0070aep84
    • The effect of surgeon’s experience on the outcome of patients with ACC

      ea0070aep85
    • VDR-GR complex reduces apoptosis in acute myeloid leukemia cells via reduction of GR transcriptional activity

      ea0070aep86
    • Cortisol response to acute stress is dependent on previous stress exposure and sex of the examined humans

      ea0070aep87
    • Investigating differences regarding stress hormonal response during vaginal delivery and elective caesarean section

      ea0070aep88
    • Apparent mineralocorticoid excess (AME): Finding the “root” cause

      ea0070aep89
    • Hypertensive crises related to the defecation strain, what’s the diagnosis?

      ea0070aep90
    • Composite pheochromocytoma of the adrenal gland: Case report

      ea0070aep91
    • Cystic pheochromocytoma, a diagnostic challenge: A case report

      ea0070aep92
    • Type 1 neurofibromatosis and malignant pheochromocytoma

      ea0070aep93
    • Results of biochemical testing in suspected primary hyperaldosteronism – a retrospective study

      ea0070aep94
    • Body composition, insulin sensitivity and blood pressure in patients with congenital adrenal hyperplasia

      ea0070aep95
    • Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS

      ea0070aep96
    • Clinical and histopathologic phenotype of a single-center patient cohort operated for unilateral primary aldosteronism

      ea0070aep97
    • Expression ofestrogen-related receptors andepidermal growth factor receptorin normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

      ea0070aep98
    • Assessment of serum adropin concentrations in primary aldosteronism

      ea0070aep99
    • Radiological and functional analysis of a cohort of adrenal adenomas

      ea0070aep100
    • Aetiological diagnosis of Cushing’s syndrome : A trap for the unwary

      ea0070aep101
    • Is glucocorticoid replacement therapy in adrenal insufficiency a risk factor for liver steatosis?

      ea0070aep102
    • Evaluation of clinical and functional differences between unilateral and bilateral adrenal incidentalomas. A spanish multicentric study.

      ea0070aep103
    • How innocent are nonfunctioning adrenal incidentalomas?

      ea0070aep104
    • Human centered design in co-creation of tool-kit for care of patients with adrenal insufficiency- an iterative quality improvement approach

      ea0070aep105
    • Study of effect of whitening creams on serum basal cortisol level in egyptian females

      ea0070aep106
    • A congenital adrenal hyperplasia patientpresented with myocardial infarction due to inadequate glucocorticoid therapy

      ea0070aep107
    • Paradoxical hypertension: The hidden risk of beta blockade

      ea0070aep108
    • Case study of family performing pheochromocytoma and paraganglioma (PPGL)

      ea0070aep109
    • Pheochromocytoma with subclinical cushing’s syndrome: A case report

      ea0070aep110
    • A rare case of spontaneous adrenal haemorrhage from an adrenal haematoma

      ea0070aep111
    • A patient with seizures and adrenal failure as systemic manifestations of miliary tuberculosis: A case report

      ea0070aep112
    • Misdiagnosis of phaeochromocytoma with multiple cerebral infarcts and complex arrhythmias, failure “to think of it”

      ea0070aep113
    • Can you diagnose drug-induced bilateral adrenitis before clinical and analytical manifestations are present?

      ea0070aep114
    • Severe hypoaldosteronism after unilateral adrenalectomy for aldosteronoma: Case report

      ea0070aep115
    • Adjuvant mitotane therapy: Predictive factors of response in adrenocortical carcinoma

      ea0070aep116
    • Diagnosis, treatment and survival of adrenocortical carcinoma: 28 years of experience

      ea0070aep117
    • CT signs and parameters of vascularization of pulmonary neuroendocrine tumours and their relationship with the development of ACTH ectopic syndrome

      ea0070aep118
    • A retrospective review of radiological and endocrine characteristics of adrenal incidentalomas,in an Irish regional hospital

      ea0070aep119
    • A 17-year-old Takotsubo cardiomyopathy patient exhibiting SDHB (+) PPGL and hypersecretion of insulin at 15 minutes after glucose loading

      ea0070aep120
    • Melatonin inhibits vascular smooth muscle cell proliferation and apoptosis through upregulation of Sestrin2

      ea0070aep121
  • Bone and Calcium
  • • Phase 3b open-label study of burosumab in adults with X-linked hypophosphatemia (XLH): Baseline and Week 12 results

      ea0070aep122
    • Usefulness of parathormone (PTH) needle washout measurement vs MIBI scintiscan in localization of parathyroid adenoma- a single--center based preliminary study

      ea0070aep123
    • «Angio Scan-01» for extraskeletal calcification assessment in patients with mineral and bone disorders in chronic kidney disease

      ea0070aep124
    • Impaired bone health at cancer diagnosis in paediatric patients

      ea0070aep125
    • Abstract unavailable

      ea0070aep126
    • Familial hypocalciuric hypercalcemia in a young man: Grey zones of the differential diagnosis in 10-year clinical follow up

      ea0070aep127
    • Ultrasound-guided laser thermal ablation for parathyroid adenomas - preliminary report

      ea0070aep128
    • The picture of primary hyperparathyroidism in Italy: Proceeding from hyperparanet survey

      ea0070aep129
    • Phase II study of the impact of AZD4017, a selective 11β-HSD1 inhibitor, on osteocalcin in post-menopausal osteopenia

      ea0070aep130
    • Changes in the relative expression of circulating microRNAs linked to bone metabolism in HIV-infected Individuals with low bone mass

      ea0070aep131
    • Denosumab associated risk of malignancy- systematic review and meta-analysis of randomized controlled trials

      ea0070aep132
    • Prevalence and determinants of radiological vertebral fractures in a cohort of patients with Klinefelter syndrome

      ea0070aep133
    • Radiofrequency Echographic Multi Spectrometry (REMS) evaluation in patients with primary osteoporosis and primary hyperparathyroidism

      ea0070aep134
    • Melatonin affects hypoxia-stressed cardiomyocyte differentiation of mouse embryonic stem cells

      ea0070aep135
    • Hypercalcaemia in pregnancy due to parathyroid adenoma – would you recognise it?

      ea0070aep136
    • Are young primary hyperparathyroidism patients differ from older ones regarding clinical and biochemical features?

      ea0070aep137
    • A new and valuable predictor for the diagnosis of primary hyperparathyroidism: Ca/P Ratio

      ea0070aep138
    • Comparative efficacy of parathyroidectomy and conservative management in patients with mild primary hyperparathyroidism: A systematic review and meta-analysis of randomized-controlled studies

      ea0070aep139
    • Prevalence of hypoparathyroidism in the EU: A systematic review and meta-analysis

      ea0070aep140
    • Identifying clinical characteristics of hypoparathyroid patients in turkey: The ‘HIPOPARATURK-NET Study’

      ea0070aep141
    • The prevalence of postoperative (PO) chronic hypoparathyroidism (HypoPTH) in bilbao, northern spain

      ea0070aep142
    • Osteocalcin may participate to the bone-parathyroid crosstalk through activation of the calcium-sensing receptor in human parathyroid adenomas

      ea0070aep143
    • Long-term effectiveness of asfotase alfa in adults with pediatric-onset hypophosphatasia in routine clinical practice

      ea0070aep144
    • Prevalence of osteoporosis, vertebral fractures and hypogonadism in HIV-infected men.

      ea0070aep145
    • Bone metabolism in patients with extreme insulin resistance (IR) syndromes

      ea0070aep146
    • Core muscles trainig for muscle strength improvement in patients with osteoporotic compression vertebral fractures

      ea0070aep147
    • Successful quantification of symptom load by a disease-specific questionnaire HPQ 40/28 and analysis of influencing biochemical parameters in patients with postsurgical hypoparathyroidism

      ea0070aep148
    • Investigation of total- and free-25OHD levels by different methods in pregnant women

      ea0070aep149
    • Analysis of 25OHD levels in chronic renal failure depending on the methods

      ea0070aep150
    • Cardiovascular status in chronic hypoparathyroidism – a single-center analysis in 133 patients compared to the general german population

      ea0070aep151
    • Renal complications in chronic hypoparathyroidism – a german single-center analysis in 169 patients

      ea0070aep152
    • Risk of fractures in primary hyperparathyroidism: A systematic review and metaanalysis

      ea0070aep153
    • Psychiatric Comorbidities in Chronic Hypoparathyroidism – a German Single-Center Analysis in 107 Patients

      ea0070aep154
    • Do near-infrared intra-operative findings by the use of indocyanine green correlate with post-thyroidectomy parathyroid function? - the ICGPREDICT study

      ea0070aep155
    • DXA scanning in primary hyperparathyroidism: Should forearm DXA be performed routinely?

      ea0070aep156
    • Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: A survey of physicians in belgium and the Netherlands

      ea0070aep157
    • Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: European subanalysis of a global patient survey

      ea0070aep158
    • Clinical features and management of primary hyperparathyroidism discovered by parathyroid incidentaloma

      ea0070aep159
    • Serum and tissue expression profile of microRNAs that regulate genes related to the pathogenesis of sporadic parathyroid adenomas

      ea0070aep160
    • The use of PET/CT with 11C-methionine for the diagnosis of a patient with renal hyperparathyroidism

      ea0070aep161
    • Oncogenic osteomalacia – from diagnosis to recovery in 7 days

      ea0070aep162
    • Case report: Refractory hypercalcemia due to a pancreatic neuroendocrine tumor misdiagnosed as adenocarcinoma

      ea0070aep163
    • Increasing incidence of parathyroid carcinoma according to russian registry of the primary hyperparathyroidism

      ea0070aep164
    • Primary hyperparathyroidism in multiple endocrine neoplasia type 1 (MEN-1) according to the online russian registry

      ea0070aep165
    • Neural network algorithm to determine the optimal range of PTH level for patients with end-stage chronic kidney disease to maintain bone metabolism

      ea0070aep166
    • The trabecular bone score predicts vertebral fragility fractures and decrease in volumetric bone mineral density in postmenopausal women

      ea0070aep167
    • Inactivation of diabetoporosity-associated miRNAs in human mesenchymal stem cells

      ea0070aep168
    • Fracture risk in patients with acute poliomyelitis‏ going through late adulthood

      ea0070aep169
    • Long term effect on trabecular bone score but not BMD is preserved in GH-deficient adults only when sufficient vitamin D levels are maintained

      ea0070aep170
    • Does real-life time spent within the therapeutic range affect degree of improvement in bone mineral density in men receiving testosterone therapy for hypogonadism?

      ea0070aep171
    • Primary hyperparathyroidism diagnosis with 18-F-fluorodioline Pet/CT (FCPCT) in a routine endocrinology praxis: Need of the new guidelines

      ea0070aep172
    • Quality of life, depressin and anxiety in patients with hypoparathyroidism

      ea0070aep173
    • Colour doppler ultrasound: Preoperative location of parathyroid adenomas in primary hyperparathyroidism

      ea0070aep174
    • Normocalcemic primary hyperparathyroidism in patients with elevated parathormone (PTH) in a regional health area. A laboratory based approach.

      ea0070aep175
    • NGS sequencing proves as a powerful method to perform differential diagnosis in patients with inactivating PTH/PTHrP signaling disorders (iPPSD)

      ea0070aep176
    • Incidence of hypercalcemia and its causes in spain in a fifteen years period (2001–2015)

      ea0070aep177
    • Management of severe hypercalcemia secondary to primary hyperparathyroidism: The efficiency of saline hydration, furosemide, and bisphosphonates.

      ea0070aep178
    • Modeling to estimate the prevalence of chronic hypoparathyroidism in the absence of population-based studies

      ea0070aep179
    • Baseline characteristics from the observational paradighm registry of patients with chronic hypoparathyroidism

      ea0070aep180
    • Clinical presentations of patients receiving PTH-therapy among the referral population with hypoparathyroidism.

      ea0070aep181
    • Clinical characteristics of subjects with very high serum 25 OH vitamin D levels in turkey: DeVIT-TOX survey

      ea0070aep182
    • The bone density and trabecular bone score in patients after solid organ transplantation

      ea0070aep183
    • Free 25-hydroxyvitamin D, but not free 1.25-dihydroxyvitamin D, predicts all-cause mortality in ageing men

      ea0070aep184
    • Calcium-sensing receptor gene polymorphisms and their effect on response to cinacalcet treatment in patients with secondary hyperparathyroidism in chronic kidney diseases

      ea0070aep185
    • An extremely rare cause of severe primary hyperparathyroidism due to intrathyroidal parathyroid cyst.

      ea0070aep186
    • Skeletal manifestations of hypoparathyroidism mimicking ankylosing spondylitis; a rare clinical presentation: A case report

      ea0070aep187
    • Hypercalcemia and primary hyperparathyroidism case progressing during the treatment of dapagliflozin

      ea0070aep188
    • Radioiodine, hyperparathyroidism and schwannoma... coincidence or consequence?

      ea0070aep189
    • Multiple endocrinopathies associated with myotonic dystrophy type 1 – case report

      ea0070aep190
    • Remission of disseminated parathyroid cancer after multiple surgical interventions because of recurrences in the neck lymph nodes, left lung and liver in a young patient with hyperparathyroidism-jaw tumor syndrome

      ea0070aep191
    • Sequencing of the gnas gene in hungarian patients with pseudohypoparathyroidism and mccune-albright syndrome

      ea0070aep192
    • Mineral density of bone tissue, parathyroid hormone and vitamin D in children and adolescents with thyrotoxicosis

      ea0070aep193
    • Assessing risk factors and predictors of mortality in patients with fragility hip fracture

      ea0070aep194
    • Bone quality is associated with perinatal nutritional manipulation in adult Wistar rats offspring

      ea0070aep195
    • Epidemiology of osteoporotic hip fracture in the largest urban area of Romania

      ea0070aep196
    • The osteoporosis and hormonal status of our thalassemia patients

      ea0070aep197
    • Follow-up report: A case of FGF23-related tumor-induced osteomalacia with pulmonary adenocarcinoma

      ea0070aep198
    • Biochemical and clinical findings distinguishing between the genetic and the acquired conditions in osteoporotic patients with low serum alkaline phosphatase levels

      ea0070aep199
    • Multiple vertebral fractures in a real-life denosumab-treated cohort: Patient level data

      ea0070aep200
    • Body composition and bone mineral density in craniopharyngioma patients: A longitudinal study over 10 years

      ea0070aep201
    • Body composition and adipokines influence upon bone mineral density and bone metabolism in renal transplant receivers

      ea0070aep202
    • Hip spine discordance in bone mineral density: Prevalence and potential significance

      ea0070aep203
    • High serum FSH is not a risk factor for low bone mineral density in infertile men

      ea0070aep204
    • Denosumab-induced hypocalcemia: Does gender play a role?

      ea0070aep205
    • Parathyroid carcinoma: An italian multicenter retrospective analysis

      ea0070aep206
    • 18Fluoro-choline PET/CT is a useful tool for patients with primary hyperparathyroidism negative at first-line imaging localization tecniques

      ea0070aep207
    • Effect of vitamin D supplementation on carotid intima media thickness in overweight and obese schoolchildren: A single blind randomized clinical trial

      ea0070aep208
    • Can serum calcium, phosphorus and parathyroid hormone levels predict histopathological diagnosis in patients with primary hyperparathyroidism?

      ea0070aep209
    • Is the assessment of clinical risk factors for vitamin D deficiency sufficient?

      ea0070aep210
    • First results of an austrian prospective hypoparathyroidism registry – the HypAus study

      ea0070aep211
    • Renal complications in patients with chronic hypoparathyroidism receiving conventional therapy: A systematic literature review

      ea0070aep212
    • Renin-angiotensin-aldosterone system in patients with primary hyperparathyroidism

      ea0070aep213
    • Gene expression of claudins in NCKX3 knockout mouse

      ea0070aep214
    • Progression of vertebral fractures in long-term controlled acromegaly: A 9-year follow-up study

      ea0070aep215
    • Assessment of physical fitness after bariatric surgery and its association with protein intake and type of cholecalciferol supplementation

      ea0070aep216
    • The Burden of chronic hypoparathyroidism in canada: A retrospective study using the institute for clinical evaluative sciences (ices) database

      ea0070aep217
    • Cinacalcet use in pregnancy for a case of multiple endocrine neoplasia (MEN) 1 - associated primary hyperparathyroidism

      ea0070aep218
    • An enlarged parathyroid gland emerging in the bed of the thyroid may mimic local recurrence in patients after total thyroidectomy for the papillary thyroid cancer: How does recovery from postsurgical hypoparathyroidism work?

      ea0070aep219
    • Fahr’s disease in primary hypoparathyroidism – a case report

      ea0070aep220
    • Varied clinical presentation of pseudohypoparathyroidism- series of three distinctive cases

      ea0070aep221
    • Testosterone, estradiol and 25-hydroxyvitamin D effects at the proximal femur in 3D analysis from a standard 2D DXA scans of adult men

      ea0070aep222
    • Trabecular bone score assessment in heart transplant recipients stratified by time after transplantation

      ea0070aep223
    • Efficacy of teriparatid therapy in resistant hypocalcemia depending postoperative hypoparathyroidism

      ea0070aep224
    • Trabecular bone score in postmenopausal women with primary hyperparathyroidism

      ea0070aep225
    • The incidence of nephrolithiasis and osteoporosis in patients with asymptomatic hyperparathyroidism

      ea0070aep226
    • Osteogenesis imperfecta type V due to a rare mutation c.119C> T in the IFITM5: A case report

      ea0070aep227
    • A case of severe asymptomatic hypercalcaemia in IgG kappa multiple myeloma, focal bone disease and inappropriately normal PTH as a differential diagnostic dilemma

      ea0070aep228
    • Trabecular bone score in subjects after simultaneous pancreas kidney transplantation

      ea0070aep229
    • Vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with Radium-223: A longitudinal study in the real-life clinical practice.

      ea0070aep230
    • A follow-up of a patient with osteopetrosis successfully treated with bone marrow transplant at the age of 28

      ea0070aep231
    • Complex physical rehabilitation effect on postural control in patients with osteoporotic vertebral fractures

      ea0070aep232
    • Abstract unavailable

      ea0070aep233
    • Brown tumor with multiple localizations in primary hyperparathyroidism: About a case

      ea0070aep234
    • The transition range and acceleration from normocalcemia to hypercalcemia in patients with primary hyperparathyroidism: Does it provide a new perspective?

      ea0070aep235
    • Role of preoperative calcium and vitamin d therapy to prevent postsurgical hypoparathyroidism

      ea0070aep236
    • Is BMD still useful when we have FRAX?

      ea0070aep237
    • Osteoporotic bone fracture hiding a rare sex chromosome disorder: Case report

      ea0070aep238
    • The assessment of risk factors for osteoporosis and probability of osteoporotic fractures in patients undergoing medical rehabilitation

      ea0070aep239
    • Hypothyroidism effect on bone tissue

      ea0070aep240
    • Bone turnover markers and bone quality between patients with hyperthyroidism and primary hyperparathyroidism

      ea0070aep241
    • Severe hypocalcemia and psuedotumor cerebri: Old, still not so well known relationship!

      ea0070aep242
  • Diabetes, Obesity, Metabolism and Nutrition
  • • Heterogeneity and diagnostic features of diabetes mellitus types in young patients

      ea0070aep243
    • Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study

      ea0070aep244
    • Assessment of arrhythmia risk due to hypoglycemia with continuous glucose monitoring device and 24-hour holter monitoring

      ea0070aep245
    • Insights from whole exome sequencing in a Maltese cohort with gestational diabetes

      ea0070aep246
    • Features of sarcopenia and body composition measured with bioimpedance in patients with diabetes mellitus type 2

      ea0070aep247
    • Evaluation of the endocrine cells ratio in the pancreas of rats with type 2 diabetes mellitus following long-term therapy with incretin mimetics and their combination with sulfonylureas drugs

      ea0070aep248
    • A multi-center, randomized, double-blind, parallel, active-controlled phase III clinical trial to evaluate the efficacy and safety of controlled-release pregabalin and immediate-release pregabalin in diabetic peripheral neuropathic pain

      ea0070aep249
    • Gestational diabetes in korea: Temporal trends in prevalence, treatment, and short-term consequences from a national health insurance claims database 2012 – 2016

      ea0070aep250
    • Twin pregnancy with gestational diabetes mellitus: Maternal and fetal outcomes

      ea0070aep251
    • Immunomodulatory and anti-diabetic actions of a structurally-modified analogue of esculentin-2CHa isolated from the skin secretion of the frog, lithobates chiricahuensis (ranidae)

      ea0070aep252
    • Congenital hyperinsulinemic hypoglycemia: A case report

      ea0070aep253
    • Chronic activation of adaptive immunity in type 2 diabetes

      ea0070aep254
    • Thrombocyting haemostasis in children with diabetes mellitus type I

      ea0070aep255
    • Fatty liver, irrespective of ethnicity, is associated with reduced insulin clearance and insulin resistance in obese youths

      ea0070aep256
    • Abstract unavailable

      ea0070aep257
    • Are we being too demanding with obese pregnant women with gestational diabetes?

      ea0070aep258
    • Randomized controlled trial of different intensities of glycemic control in women with gestational diabetes

      ea0070aep259
    • Weight loss through lifestyle modification or liraglutide is associated with improvement of NAFLD severity and changes in amino acid concentrations

      ea0070aep260
    • Lack of mitochondrial medium chain acyl-coenzyme A synthetase Acsm3 in an inbred rat strain with diet-induced hypertriglyceridemia and insulin resistance

      ea0070aep261
    • Evaluation of serum and salivary subfatin and asprosin hormone levels in patients with nonalcoholic steatohepatisis

      ea0070aep262
    • Capabilities of ultrasonography in diagnosis of latent post-injection lipodystrophies

      ea0070aep263
    • Evaluation of glycemia course in patients with diabetes mellitus type

      ea0070aep264
    • Hand grip strength is correlated with peripheral neuropathy and metabolic control in patients with diabetes

      ea0070aep265
    • Association between gestational glycemic profile and delivery with a large for gestational age baby in pregnant women with type 1 diabetes

      ea0070aep266
    • Peculitaries of markers of renal function in patients with Diabetic Kidney Disease depending on C/T polymorphism in the DIO 1 gene

      ea0070aep267
    • Association of the APOEgene polymorphism with diabetic nephropathy

      ea0070aep268
    • Characterizing familial partial lipodystrophy: Baseline data of the BROADEN study

      ea0070aep269
    • A comparison of the level of appetite, food intake, metabolic hormones, basal metabolic rate and adiposity in normal and short stature children

      ea0070aep270
    • MODY5 with a whole deletion of HNF1B based on 17q12 microdeletion in a patient with primary amenorrhoea due to severe genitalabnormalities

      ea0070aep271
    • Difficulties in diagnosing of artificial hypoglycemia: Insulin analogues

      ea0070aep272
    • Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-Cell peptides: Results from the HIPER-1 study

      ea0070aep273
    • The influence of simultaneous pancreas-kidney transplantation on the evolution of diabetic foot lesions and peripheral arterial disease

      ea0070aep274
    • Female AKR1D1 knockout mice have impaired intestinal health with evidence of gut dybiosis, increased gut permeability and an increased incidence of colon cancer

      ea0070aep275
    • Metabolic and cardiovascular consequences of Ramadan fasting in type 2 diabetic patients

      ea0070aep276
    • Association and predictive ability of maternal body composition parameters in early pregnancy to identify gestational diabetes mellitus

      ea0070aep277
    • Glucose metabolism and lipid profile in centenarians: What can they predict?

      ea0070aep278
    • Association of FT3 levels and FT3/FT4 ratio in the first trimester with the risk of developing gestational diabetes

      ea0070aep279
    • Protein Kinase Cα attenuates neuronal insulin signalling and worsen neuronal insulin-resistance

      ea0070aep280
    • The MAFA gene mutation responsible for familial insulinomatosis and diabetes impairs insulin secretion and results in downregulation of critical cell cycle regulators

      ea0070aep281
    • Residual fasting C-peptide secretion and its association with glycemic control in type 1 diabetes

      ea0070aep282
    • Identification of a diagnostic and prognostic miRNA signature in women with gestational diabetes mellitus

      ea0070aep283
    • Inflammasome components and food addiction behaviors in morbid obesity and bariatric surgery: Novel promising targets for a chronic disease

      ea0070aep284
    • Secretion of bile acids in different techniques of bariatric surgery

      ea0070aep285
    • Liraglutide and PYY_3–36 combination therapy partially achieves the metabolic benefits of Roux-en-Y gastric bypass surgery in diet-induced obese rats

      ea0070aep286
    • The day-to-day variability of insulin sensitivity measured during ogtt in young adult males

      ea0070aep287
    • Association between the circadian rhythm and the inhibitory effect of glucocorticoids on browning of adipocytes

      ea0070aep288
    • Association of nutritional support with in-hospital mortality in malnourished medical inpatients – a population-based cohort study

      ea0070aep289
    • Magnesium supplementation and higher magnesium levels in T2DM patients are associated with better glycemic control and higher rates of total and partial remission post-bariatric surgery

      ea0070aep290
    • Nesfatin-1, an appetite-suppressing and anti-obesogenic neuropeptide, is decreased in the human brainstem of obese subjects.

      ea0070aep291
    • Digital evaluation of ketosis and other diabetes emergencies (DEKODE) algorithm: Automated auditing system for diabetic ketoacidosis (DKA) management

      ea0070aep292
    • Type 2 diabetes did not show significant risk effect on cerebral aneurysm in Koreans: A single center, cross-sectional study

      ea0070aep293
    • Fibroblast growth factor 21 (FGF21) in hyper- and hypothyroidism, association with metabolic disturbances

      ea0070aep294
    • Excess risk of thyroid cancer in individuals with type 1 diabetes compared to those without diabetes in Finland; nationwide study

      ea0070aep295
    • Pulse wave velocity and circulating Retinol binding protein 4: A cross sectional association in early postmenopausal women

      ea0070aep296
    • Metabolic syndrome severity score for predicting cardiovascular events: A nationwide population-based study from Korea

      ea0070aep297
    • High prevalence of cognitive dysfunction and vitamin B12 deficiency in patients with type 2 diabetes over 50 years

      ea0070aep298
    • Prevalance of undiagnosed dementia in young diabetic population in central india

      ea0070aep299
    • Features of phenotypes of diabetic kidney disease depending on the type of underlying disease

      ea0070aep300
    • Maturity- onset diabetes of the young type 6 (MODY6): A case report of two relatives (mother and daughter) with undescribed heterozygous variant of mutation in NeuroD1 gene

      ea0070aep301
    • Challengesrelated to prevention and management of diabetes mellitus inprimary healthcare settings

      ea0070aep302
    • An assessment into the insulin secretion during visceral leishmaniasis

      ea0070aep303
    • Diagnostic accuracy of fatty liver index in type 1 diabetes mellitus patients

      ea0070aep304
    • CTRP-1 levels are related to insulin resistance in gestational diabetes mellitus

      ea0070aep305
    • New-onset diabetes mellitus after liver transplantation in the patients with acute liver failure: Is there any effect of pretransplant hypoglycemia?

      ea0070aep306
    • Perception regarding marriage of diabetics in central indian population

      ea0070aep307
    • Effect of maternal obesity and degree of glucose intolerance on neonatal hypoglycaemia and birth weight: A retrospective observational cohort study in women with gestational diabetes mellitus

      ea0070aep308
    • Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I

      ea0070aep309
    • Characterization of muscle function, lifestyle and motivational indices in obese women

      ea0070aep310
    • Study of the effect of sibutramine on central mechanisms of regulation of eating behavior in patients with obesity by means of fMRI. Preliminary results

      ea0070aep311
    • Combination of baseline body weight with active plasma ghrelin level could predict early response with liraglutide 3.0 mg in patients with obesity

      ea0070aep312
    • Omega-3 PUFA and probiotics as a single formulation for insulin resistance and obesity: Evidence from animals to randomized clinical studies

      ea0070aep313
    • Antibodies to insulin receptor in the diagnosis of non-diabetic hypoglycemia

      ea0070aep314
    • Time to glycemic control – an observational study of 3 different operations

      ea0070aep315
    • Appropriateness of the 6 mm insulin needle length comparing the glycemic control in overweight-obese and normal weight patients with type 2 diabetes – four years observational study

      ea0070aep316
    • Pancreas-kidney transplantation improves quality of life in type 1 diabetes patients

      ea0070aep317
    • Glycemic control in patients with acute myocardial infarction in an intensive care unit

      ea0070aep318
    • Vitamin D supplementation and glucose metabolism parameters in pre-diabetic women

      ea0070aep319
    • Euglycemic DKA after initiating an SGLT-2 Inhibitor and the P90X diet

      ea0070aep320
    • Severe insulin resistance with cirrhosis: A case report

      ea0070aep321
    • Switching from liraglutide to dulaglutide, is it worth it?: Outcomes at 24 weeks follow-up

      ea0070aep322
    • The impact of new technologies on metabolic control in children with type 1 diabetes mellitus during early and middle childhood

      ea0070aep323
    • Long-term efficacy and safety of flash glucose monitoring system: 30-month real-life experience

      ea0070aep324
    • Evaluation of the effects of phone support programme for patients with type 2 diabetes in treatment with insulin glargine 300 u/ml (T-coah)

      ea0070aep325
    • Inappropriately elevated serum C-peptide after dosing may interfere with PK and/or PD measurements of study insulin in a euglycemic clamp

      ea0070aep326
    • Metabolic effects of semaglutide after the first months of treatment: A new GLP-1-RA revolution?

      ea0070aep327
    • The icone study’: Multicenter evaluation of the impact of contour next one and contour diabetes app on self-management and adherence in insulin-treated patients with diabetes type 1 or 2

      ea0070aep328
    • Experience of using insulin therapy with the closed loop method among patients with type 1 diabetes mellitus in Russia

      ea0070aep329
    • Use of statins and cognitive performance in elderly type 2 diabetic patients

      ea0070aep330
    • Clinical and metabolic benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) therapy in diabetic patients with psychiatric comorbidities

      ea0070aep331
    • Immune checkpoint inhibitors (ICIs) and ‘Fulminant Diabetes’: Two emblematic cases

      ea0070aep332
    • Vitamin B12 levels and its association with glycaemic control and pregnancy outcomes in women with gestational diabetes

      ea0070aep333
    • Abstract unavailable

      ea0070aep334
    • Study on lipid compositions of the skeletal and liver tissues in animals with the induced alimentary obesity and insulin resistance

      ea0070aep335
    • Studying the care and social pathway of young adults with endocrine and metabolic diseases during transition: The ‘Transend’ cohort

      ea0070aep336
    • The complexity of associations between type 2 diabetes mellitus and comorbidities in multimorbid population in Lithuania

      ea0070aep337
    • Lipoprotein (a) in patient with type 2 diabetes mellitus and healthy subjects

      ea0070aep338
    • Correlation between BMI and cognitive performance in type 2 diabetic patients

      ea0070aep339
    • Prevalence and prognosis impact of diabetes in cirrhotic patients

      ea0070aep340
    • Anti-Lipogenic effects of cabergoline: A molecular study on white adipocytes

      ea0070aep341
    • Modification of standard thresholds improves performance of noninvasive scores of liver fibrosis in patients undergoing bariatric surgery

      ea0070aep342
    • Effects of bariatric surgery on heart rhythm disorders: A systematic review and meta-analysis

      ea0070aep343
    • Physical activity is associated with lower arterial stiffness after the menopause: The effect of BMI

      ea0070aep344
    • Role of an automated screening tool in familial hypercholesterolemia

      ea0070aep345
    • Sodium taurocholate cotransporting polypeptide (NTCP) is a new and promising target for treatment of hypercholesterolemia: A proof of concept from a randomized double-blind placebo-controlled phase I trial

      ea0070aep346
    • Prevalence andassociated factors with sensitive neuropathy in a population of patients with diabetes

      ea0070aep347
    • Assessment of renal insufficiency in the absence of albuminuria in patients with type 2 diabetes mellitus

      ea0070aep348
    • Rhinosinusal mucormycosis: A devastating infection in diabetes Mellitus

      ea0070aep349
    • PHIGNA-DM2 study: Fatty liver and nonalcoholic steatohepatitis prevalence in type 2 diabetes in an andalusian cohort

      ea0070aep350
    • Evaluation of clinical factors predictive of diabetes remission after bariatric surgery

      ea0070aep351
    • The relationship between cardiovascular autonomic neuropathy and markers of oxidative stress in patients with type 2 diabetes mellitus

      ea0070aep352
    • Relationship between pregnancy induced hypertension in women with gestational diabetes mellitus and proinflamatory cytokines

      ea0070aep353
    • The pattern of nerve involvement in type 1 diabetic patients with subclinical peripheral neuropathy

      ea0070aep354
    • Nursing networking for insulin pump therapy

      ea0070aep355
    • Effect of lipid metabolism of mothers with type 1 diabetes and obesity on clinical and laboratory parameters of their newborns

      ea0070aep356
    • Different steroidogenesis in patients with alzheimer’s disease and Type 2 diabetes mellitus

      ea0070aep357
    • The trio of severe hypertriglyceridemia, acute pancreatitis and diabetic ketoacidosisin a young subject not known before with diabetes. A case report

      ea0070aep358
    • Case of type 1 diabetes development after programmed cell death-1 inhibitor immunotherapy

      ea0070aep359
    • Arare case of caucasian patient with insulin autoimmune syndrome induced by a-lipoic acid

      ea0070aep360
    • Autoimmune causes of hypoglycemia

      ea0070aep361
    • Cardiovascular manifestation of alkaptonuria

      ea0070aep362
    • The quantitative relationship between Autonomous cortisol secretion, Dysglycemia and the Metabolic syndrome

      ea0070aep363
    • In vitro and in vivo insulinotropic actions of magainin-AM1 on pancreatic beta cells and high fat fed mice

      ea0070aep364
    • The acute effects of short-term insulin therapy on the secretory ability of beta cells in patients with diabetes mellitus type 2, after the secondary failure of the oral therapy

      ea0070aep365
    • Clinical pharmacology of insulin aspart: Hyperinsulinemic euglycemic clamp study of the biosimilar product

      ea0070aep366
    • Does short term intensive insulin therapy in newly diagnosed type 2 diabetes mellitus delay eventual insulin dependence?

      ea0070aep367
    • Nurse education in diabetes and endocrinology – important part of the improvement of care provided to people with diabetes and other endocrine disorders

      ea0070aep368
    • Insulin regulated aminopeptidase (IRAP) inhibition affects glucose metabolism in obese pre-diabetic Zucker rats

      ea0070aep369
    • Relationship of blood dopamine and leptin with anthropometric data in childhood obesity

      ea0070aep370
    • The influence of obesity on changes in adipokines during the menstrual cycle

      ea0070aep371
    • The effect of SNP (rs174537) in FADS1 gene on fatty acid composition in serum lipids

      ea0070aep372
    • The educational training to the Mediterranean diet-like pattern is followed by improvement in cardiometabolic parameters and ecology of the microbiome in children with obesity: Preliminary results of the GOOD DAY trial

      ea0070aep373
    • Liraglutide downregulates the expression of miRNA-424 in patients with obesity

      ea0070aep374
    • Predictors of metabolic disease in normal weight postmenopausal women: A cross-sectional study

      ea0070aep375
    • Phase angle (PA) and body composition changes in obese patients with associated comorbidities (by AACE criteria) through a very low calorie diet (VLCD) program

      ea0070aep376
    • The additive effect of obesity in the incidence of neurocognitive disorders in offspring of women with gestational diabetes

      ea0070aep377
    • Bariatric surgery impact on cardiovascular risk factors: Is age a factor to consider?

      ea0070aep378
    • TGFβ1 downregulates hepatic SHBG production by decreasing HNF-4α levels via SMAD and STAT3 pathways

      ea0070aep379
    • Cryptogenic cirrhosis and metabolic syndrome: What relationship?

      ea0070aep380
    • Association of osteoprotegerin and metabolic status in children with obesity

      ea0070aep381
    • Different effects of 5α-dihydrotestosterone treatment on hepatic and visceral adipose tissue inflammation in animal model of polycystic ovary syndrome

      ea0070aep382
    • Association of AdipoQ gene & its expression in adipose tissue with post prandial hypertriglyceridemia and glucose intolerance

      ea0070aep383
    • Evaluation of macrovascular complications with Ankle-Brachial index in Type 2 diabetes

      ea0070aep384
    • Maternally inherited diabetes and deafness presenting as diabetic ketoacidosis

      ea0070aep385
    • Association of depressive symptoms and diabetes-related distress with glycemic control, self-care activities and quality of life in diabetic patients

      ea0070aep386
    • Albuminuria and carotid intima-media thickness as surrogate markers of atherosclerosis in asymptomatic patients with type 2 diabetes

      ea0070aep387
    • Exacerbations of psoriasis in patients with type 2 diabetes

      ea0070aep388
    • Disordered eating behaviour in type 2 diabetic patients receiving oral hypoglycemic drugs

      ea0070aep389
    • Insulin need and determinants of insulin usage in diabetes mellitus during pregnancy

      ea0070aep390
    • Arginine metabolism and gut microbiota changes in pediatric patients with type 1 diabetes

      ea0070aep391
    • Freestyle libre flash glucose monitoring system in pregnant woman affected by type 1 diabetes: Our experience

      ea0070aep392
    • 2-hr vs 1-hr glucose tolerance testing for pre-DM diagnosis, among HIV-infected patients

      ea0070aep393
    • Thiamine-responsive megaloblastic anemia syndrome with dysrhythmia

      ea0070aep394
    • Betamethasone administration in pregnant women with pre-existing diabetes mellitus

      ea0070aep395
    • Falling insulin requirements in women with pregestational diabetes

      ea0070aep396
    • Exposure to phenolic compounds (Bisphenol A and Methyl Paraben) in pregnancy and its relationship with gestational diabetes mellitus, insulin homeostasis and pancreatic beta cell function

      ea0070aep397
    • The prophylactic effects of metoprolol, diltiazem and pilocarpine on hypoglycemia-induced prolongation of QT interval

      ea0070aep398
    • Serum vaspin level in patients with diabetes mellitus type 2 as a predictive index of atherosclerosis

      ea0070aep399
    • Systematic screening reveals large number of undiagnosed and untreated cardiovascular risk factors in adults with prader-willi syndrome

      ea0070aep400
    • The severity of insulin resistance in hypertensive patients depending on triglyceride-glucose index

      ea0070aep401
    • Fish oil and metformin combination to target dyslipidemia in women with polycystic ovarian syndrome

      ea0070aep402
    • Epicardial fat accumulation and coronary artery calcification in non-alcoholic fatty liver disease

      ea0070aep403
    • Effects of azilsartan vs telmisartan on insulin resistance and metabolic biomarkers in patients of essential hypertension associated with type 2 diabetes mellitus: An open-label, randomized clinical trial

      ea0070aep404
    • Aldo-keto reductase (AKR) 1C1 – a potential driver of cell cycle progression in hepatocellular carcinoma

      ea0070aep405
    • Connection of glucose control with the 25-OH vitamin D status in type 1 diabetic young patients

      ea0070aep406
    • Microangiopathy and cardiovascular risk in type 2 diabetic population

      ea0070aep407
    • Prolonged QT interval during diabetic ketoacidosis: A case series

      ea0070aep408
    • Factors associated with good knowledge of foot health in a population of patients with diabetes

      ea0070aep409
    • Foot self-care practices of Diabetic patients in Tunisia

      ea0070aep410
    • Particularities of the evolution of type 1 diabetes in 102 Tunisian adolescents

      ea0070aep411
    • Relationship between chronic pancreatitis and non-alcoholic fatty liver disease in patients with type 2 DM

      ea0070aep412
    • Fungal necrotizing external otitis in diabetic patients

      ea0070aep413
    • Non-alcoholic fatty liver disease and type 2 diabetes mellitus: Diagnostic methods

      ea0070aep414
    • Association between diabetic peripheral neuropathy (DPN) and hypertiglyceridemia in patients with type 2 diabetes in georgia

      ea0070aep415
    • Hypoglycaemia during ramadan in patients with diabetes from Tunisia

      ea0070aep416
    • Clinical and metabolic impact of ramadan fasting in tunisian patients with diabetes

      ea0070aep417
    • Cognitive impairment in patients with type 2 diabetes is associated with increased level of circulating Granzyme B

      ea0070aep418
    • Clinical evidence of the cost effectiveness of bariatric surgery in management of type 2 diabetes mellitus and obesity to prevent associated co-morbidity

      ea0070aep419
    • Pecularities of bile homeostasis in patients with chronic cholecystitis combinedwith diabetes mellitus type 2

      ea0070aep420
    • Pecularities of antithyroid autoimmunity indicators in patients with diabetes mellitus type 2 depending on leptin level and impact of selenium-containing medicines intake on their titers

      ea0070aep421
    • The associations between adipocytokines and future vascular complications in type 2 diabetes

      ea0070aep422
    • Serum osteoprotegerin level in relation to ankle brachial index among type 2 diabetic patients with subclinical hypothyroidism

      ea0070aep423
    • The role of peripheral serotonin in obese wistar rats studied by using of LP533401

      ea0070aep424
    • Determining the nutrition, sleep quality and body composition conditions of working shift workers in furniture production

      ea0070aep425
    • Effects of bariatric surgery in patients with craniopharyngioma

      ea0070aep426
    • Relationship between blastocystis sp. parasitization and metabolic syndrome in an obese spanish population

      ea0070aep427
    • Adiponectin and omentin-1 concentrations in patients with systemic sclerosis

      ea0070aep428
    • The management of nonalcoholic fatty liver disease with a choline containing antioxidant compound

      ea0070aep429
    • Muscle endocrinology and its relation with liver disease

      ea0070aep430
    • Differential miRNA expression profile in adipose and muscle tissue of obese individuals with T2DM

      ea0070aep431
    • Do early gestation maternal body composition parameters identify neonates born large for gestational age?

      ea0070aep432
    • Associations between FSH levels and indices of total and regional obesity in women after menopause

      ea0070aep433
    • Thyroid stimulating hormone, insulin resistance and leptin in patients with obesity after bariatric surgery

      ea0070aep434
    • Fructose-induced alterations of hepatic lipid metabolism are modulated by chronic stress in male rats

      ea0070aep435
    • Autoimmune polyglandular syndrome type ii presenting as an endocrine emergency

      ea0070aep436
    • Hepatic steatosis indices as a predictors of vitamin D3 deficiency in patients with non-alcoholic fatty liver disease and type 2 diabetes

      ea0070aep437
    • Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer

      ea0070aep438
    • HbA1c in the diagnosis of dysglycemia

      ea0070aep439
    • Diabetic ketoacidosis with hypertriglyceridemia-induced acute pancreatitis as first presentation of diabetes mellitus associated with risperidone treatment, a case report

      ea0070aep440
    • Does the association between patterns of fruit and vegetables and metabolic syndrome incidence vary according to lifestyle factors and socioeconomic status?

      ea0070aep441
    • Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: About a case report

      ea0070aep442
    • Results of survey of patients trained in the outpatient diabetes school

      ea0070aep443
    • Factors associated with being underweight among diabetic outpatient in Cotonou

      ea0070aep444
    • Prevalence of dyslipidemia in elderly diabetics

      ea0070aep445
    • Real-time continuous glucose monitoring impact on the metabolic control over the summer in children with type 1 diabetes

      ea0070aep446
    • The impact of real-time continuous glucose monitoring on metabolic control in children with type 1 diabetes

      ea0070aep447
    • Phospholipid metabolism in patients with type I and 2 diabetes mellitus

      ea0070aep448
    • High prevalence of psychiatric disorders and its association with worse glycemic control in patients with type 1 diabetes

      ea0070aep449
    • Congenital anomaly of the kidney and urinary tract and mody 5 due to 17Q12 deletion syndrome; a case report

      ea0070aep450
    • Sleep quality of diabetic patients with metabolic syndrome, is therea difference?

      ea0070aep451
    • Retinol-binding protein in the diagnosis nafld and type 2 diabetes

      ea0070aep452
    • Prevalence of disordered eating behaviour in type 2 diabetic patients receiving insulin

      ea0070aep453
    • Constructing a model for the differential diagnosis MODY diabetes and type 2 diabetes

      ea0070aep454
    • Acidosis is not a sine qua non for DKA

      ea0070aep455
    • Effect of dietary intake of branched chain amino acids on type 2 diabetic patients

      ea0070aep456
    • Real-life clinical experience with GLP1 analogs and SGLT2 inhibitors in the treatment of diabetes type 2 and obesity

      ea0070aep457
    • Glucose scan behaviour in people with type 1 diabetes using flash glucose monitoring in a real-world setting

      ea0070aep458
    • Mediterranean diet as a novel adjuvant treatment for type 1 diabetes

      ea0070aep459
    • Impact of interval walking training on albuminuria and leptin/adiponectin ratio in patients with type 2 diabetes mellitus

      ea0070aep460
    • The effect of empagliflozin treatment on biomarkers of fibrosis in patients with type 2 diabetes and a very high risk of cardiovascular events

      ea0070aep461
    • Effects of semaglutide on glycemic control and body composition in patients with type 2 diabetes mellitus and obesity in a real life setting in spain

      ea0070aep462
    • Study on hypoglycemic effect of polyphenolic compounds isolated from the Euphorbia L. plants growing in uzbekistan

      ea0070aep463
    • The effectiveness of glucagon-like peptide 1 receptor agonist and prebiotic on short-chain fatty acids and carbohydrate metabolism in patients with carbohydrate metabolism violation

      ea0070aep464
    • Adherence with lipid treatment guidelines in Swiss patients with diabetes mellitus – results from the SwissDiab study

      ea0070aep465
    • Effectiveness of PCSK9 inhibitors in familial hypercholesterolemia in asturias, spain

      ea0070aep466
    • Outcomes of long pouch roux-en Y gastric bypass (LPRYGB): 4-years experience in primary and revision cases

      ea0070aep467
    • The relationship between estradiol and obesity in men

      ea0070aep468
    • Role of biochemical indices in the pathogenesis of metabolic syndrome

      ea0070aep469
    • Sleeve gastrectomy with loop duodenal switch (Fixed common channel) – Modification of single anastomosis duodenoileal bypass with sleeve for diabesity: An Institutional experience

      ea0070aep470
    • Circulating steroid hormones and BMI in men

      ea0070aep471
    • AKR1D1 regulates androgen availability in vitro by generating metabolites that are unable to activate the androgen receptor

      ea0070aep472
    • Refeeding syndrome – an unexpected clinical case

      ea0070aep473
    • Clinical analysis of three families caused by mitochondrial DNA mutation A3243G

      ea0070aep474
    • Descriptive analysis of body composition and phase angle (PA) in achondroplastic patients: Case-control study

      ea0070aep475
    • A comparative analysis of the impact of the filipino plate method ‘Pinggang Pinoy’ vs standard nutrition education on food group proportions and 2-hour postprandial blood sugar levels of filipino diabetes patients

      ea0070aep476
    • Comparison of basal metabolism rate assessment in athletes using indirect calorimetry, bioimpedance, and wearable monitors

      ea0070aep477
    • Effectiveness of the low-calorie diet and exercise as an adjunct to the orlistat for the sustained change in metabolic parameters in young patients with type 2 diabetes with obesity

      ea0070aep478
    • The effect of demographic factors on obesity in children (COSI project 2019), preliminary results

      ea0070aep479
    • Investigating the role of olfactory receptors in endometrial cancer cells

      ea0070aep480
    • Nesidioblastosis a rare cause of hipoglycemia in adults

      ea0070aep481
    • Adherence to treatment in 102 tunisian adolescents with type 1 diabetes

      ea0070aep482
    • Evolution of lipidic parameters in a population of patients with type 2 diabetes after switching on insulin analogs

      ea0070aep483
    • Flash glucose monitoring system: Impact on glycaemic control and body mass index in type 1 diabetes mellitus

      ea0070aep484
    • Effect of ramadan’s fastingon the glycemic balance of a diabetic population with an HbA1C before the fast greater than 10%

      ea0070aep485
    • Glycemic variability in type 1 diabetes

      ea0070aep486
    • Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to a glucagon-like peptide-1 receptor agonist: A real-world experience

      ea0070aep487
    • Evaluation of the results obtained with flash continuous glucose monitoring in patients with type 1 diabetes after a structured training program

      ea0070aep488
    • The association of vitamin B12 deficiency with metformin uses

      ea0070aep489
    • Clinical and safety profile of empagliflozin in nepalese type 2 diabetes patients

      ea0070aep490
    • The efficacy of dulaglutide in the treatment of patients with type 2 diabetes and NAFLD in real clinical practice

      ea0070aep491
    • Association of B12 levels with metformin use in type 2 diabetes patients

      ea0070aep492
    • Insulin usage and injection practices in a largeIndian cohort: An audit

      ea0070aep493
    • Vitamin D, osteoprotegerin and metabolic status in children with obesity

      ea0070aep494
    • Is body mass indexbefore the fast of the month of ramadan associated with the evolution of lipid parameters in diabetic women?

      ea0070aep495
    • Interrelationship between fasting evaluation of insulin sensitivity, body composition, physical activity and total energy expenditure in obese males

      ea0070aep496
    • The effectiveness of complex treatment of obesity on theknee osteoarthritisand the dynamics of cytokines, depending on the degree of weight loss

      ea0070aep497
    • Evolution of comorbidities associated with obesity one year after bariatric surgery, our hospital experience

      ea0070aep498
    • Obesogens and obesity pandemic

      ea0070aep499
    • Comparative effectiveness of three methods for body composition assessment in the verification of manifestations of sarcopenia in obese patients

      ea0070aep500
    • Combination of topiramate and empagliflozin is considered a good option for treatment of obesity

      ea0070aep501
    • Different short-term responses of image dissatisfaction and distortion to sleeve gastrectomy

      ea0070aep502
    • Impact of isoflavone intervention on microbiota, predicted metagenome and metabolic profile in polycystic ovary syndrome

      ea0070aep503
    • Genetic variability in antioxodative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome

      ea0070aep504
    • Challenging hypoglycaemia management in a patient with metastatic insulinoma

      ea0070aep505
    • Does the pilgrimage increase the podiatry risk in diabetic patients?

      ea0070aep506
    • Diabetic foot: An important, yet underestimated complication in albanian healthcare

      ea0070aep507
    • Diabet foot unit of the marqués de valdecilla university hospital: A data-analytic look of a multidisciplinary team

      ea0070aep508
    • Lower urinary tract symptoms in patients with metabolic syndrome and life quality impact: Preliminary results

      ea0070aep509
    • Fungal necrotizing otitis externa in diabetic patients: Clinical features and diagnostic difficulties

      ea0070aep510
    • HNF1A MODY revealed by recurrent hypoglycemia

      ea0070aep511
    • Development of diabetic complications in patients with type 2 diabetes mellitus and impaired circadian rhythms

      ea0070aep512
    • Anemia is associated risk factor of chronic kidney disease in diabetes type 2 patients

      ea0070aep513
    • Lipid metabolism in patients with diabetic nephropathy

      ea0070aep514
    • Increased ultra sensitive CRP: Abiomarker of microvascular risk in men with type 2 diabetes

      ea0070aep515
    • Evaluation of anxiety frequency in school-aged children with diabetes mellitus type 1 depending on carbohydrate metabolism compensation

      ea0070aep516
    • Prevalence of peripheral and cardiac autonomic neuropathy in hypertensive pre-diabetic georgian patients by Sudoscan

      ea0070aep517
    • Hyperuricemia as independent cardiovascular risk factors in T2D

      ea0070aep518
    • Neurological disorder in a patient with decompensated T2DM

      ea0070aep519
    • Short and long-term glycemic variability associated with severe hypoglycemia and retinopathy in type 1 diabetes mellitus

      ea0070aep520
    • Baseline characteristics of a cohort of type 1 diabetes patients on continuous subcutaneous insulin infusion therapy. Evaluation of glycemic variability parameters and complications.

      ea0070aep521
    • The role of tau-protein in the diagnosis of cognitive impairment in diabetes

      ea0070aep522
    • Diabetic muscle infarction: A life changing diagnosis with poor long term prognosis

      ea0070aep523
    • The connection between dopamine activated AVP release regulation and sugar substitutes

      ea0070aep524
    • Hyponatraemia in hospital care

      ea0070aep525
    • Triglyceride and glucose (TyG) index is an effective biomarker to identify severe acute pancreatitis

      ea0070aep526
    • Hormonal function of muscles in acromegaly in relation to metabolic disorders

      ea0070aep527
  • Endocrine-related Cancer
  • • Sarcopenia can predict response to therapy in NSCLC patients treated with PD-1 inhibitors: A longitudinal prospective study.

      ea0070aep528
    • An Endocrine and metabolic interactomic approach to identify novel diagnostic/prognostic biomarkers and therapeutic targets in gliomas

      ea0070aep529
    • Reversal effect of Vitamin D (VitD) on exosome-mediated everolimus resistance (EveR) in hepatocellular carcinoma (HCC) cell line: A molecular study

      ea0070aep530
    • Diazoxide-induced diabetic ketoacidosis in a patient with insulinoma

      ea0070aep531
    • Atypical multiple endocrine neoplasia: A case report

      ea0070aep532
    • Follow-up case report of an endoscopic ultrasound-guided ethanol ablation: An alternative option for the treatment of pancreatic insulinoma

      ea0070aep533
    • Diverse regulation of HIF-1 on VEGF in renal cell carcinoma

      ea0070aep534
    • Endocrine related immune adverse events associated with programmed death ligand-1 (PD-L1) therapy in hematologic malignancies: A retrospective analysis

      ea0070aep535
    • Real medical challenges in the diagnostic of gastrinomas

      ea0070aep536
    • Pheochromocytoma due to TMEM127 mutation – the importance of genetic test for clinical decision

      ea0070aep537
    • Functional and morphologic response to somatostatin analogues of a pancreatic gastrinoma with unusual presentation

      ea0070aep538
    • Involvement of the splicing machinery in the antitumoral actions of metformin in prostate cancer

      ea0070aep539
    • Hyponatremia and dermatomyositis as the first manifestations of small cell lung cancer

      ea0070aep540
    • Correlation of chromogranin a and standard metabolic parameters in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

      ea0070aep655
  • Environmental Endocrinology
  • • Bisphenols release from dental composite materials

      ea0070aep541
    • A monitoring project to study nationwide trends of endometriosis incidence for environmental purposes inFrance: First step results

      ea0070aep542
  • General Endocrinology
  • • Vasoinhibin dimerization and measurement in human sera with a new vasoinhibin elisa

      ea0070aep543
    • Expanding the clinical and genetic spectrum of 17α-Hydroxylase/17,20-Lyase deficiency: 7 cases and 5 novel mutations in the CYP17A1 gene

      ea0070aep544
    • Mental disorders in adult patients with diencephalon lesions by craniopharyngiomas.

      ea0070aep545
    • Late effects of allogeneic stem cell transplants on the endocrine and metabolic systems

      ea0070aep546
    • Joining forces in endocrine cancer genetics

      ea0070aep547
    • Patient perception and views on quality of care for rare endocrine diseases. Results from an EndoERN survey

      ea0070aep548
    • True hyponatremia – An unusual side effect of IV Immunoglobulins

      ea0070aep549
    • Publication outcome of abstracts presented at European Congress of Endocrinology via web scraping and automated searches

      ea0070aep550
    • TNF-α induces hyperpolarization in agrp neurons without affecting pomc neurons of the arcuate nucleus

      ea0070aep551
    • The extent of variation in the reporting of clinical activity by reference centres in the field of rare pituitary and thyroid disorders within Endo-ERN, a new reference network for rare endocrine conditions in Europe

      ea0070aep552
    • ‘I would say this is a good clinic for friends & family to be looked after in if they need similar treatment or care’ – Young Adult Endocrine (YAE) Service Evaluation

      ea0070aep553
    • Neurofibromatosis type 1: About two cases

      ea0070aep554
    • Invivo endocrine internet: An unique model of endocrine system

      ea0070aep555
    • Autoimmune polyglandular syndrome (APS) type 2 associated with chronic kidney disease

      ea0070aep556
    • Role of endocrine specialist nurse in early inpatient discharge

      ea0070aep557
    • Delay in diagnosis and clinical course of autoimmune polyglandular syndrome

      ea0070aep558
    • Activity of pure, novel and non-steroidal molecules as inhibitors of AK1C enzyme

      ea0070aep559
  • Pituitary and Neuroendocrinology
  • • Proliferation index (Ki67) is a powerful predictor of recurrence in pituitary adenoma

      ea0070aep560
    • The expression level and binding affinity of glucocorticoid receptors in patients with Cushing’s syndrome

      ea0070aep561
    • Treatment of acromegalic osteopathy in the real-life clinical practice: The baac (bone active drugs in acromegaly) multicenter study

      ea0070aep562
    • Macrophages involvement in neuroendocrine tumor behaviour and progression

      ea0070aep563
    • Cushing’s syndrome & disease: Why does it take so long to diagnose; is the interdisciplinary medical team aware of the signs and symptoms; what are the consequences?

      ea0070aep564
    • Hypercortisolism-related molecular signature: Results from whole blood methylome analysis

      ea0070aep565
    • Plasma microRNA levels in patients with active acromegaly

      ea0070aep566
    • Multigene liquid biopsy (NETest) is diagnostic of pancreatic and small bowel neuroendocrine tumours and correlates with imaging

      ea0070aep567
    • Modelling neuroendocrine tumours using 3 dimensional cell culturing

      ea0070aep568
    • Difference in plasma miRNA levels in inferior petrosal sinus samples from patients with ACTH-dependent Cushing’s syndrome as assessed by next-generation sequencing (NGS).

      ea0070aep569
    • Challenges in the management of pituitary involvement in granulomatosis with Polyangitis (GPA): 2 cases managed at Imperial college healthcare trust

      ea0070aep570
    • Deletion of chromosome 1q24-1q32 and combined pituitary hormone deficiency type 4: Insight into the challenges of genotype-phenotype correlation

      ea0070aep571
    • Baseline IGF-I values influence the effect of rhGH therapy on fat mass: Short, medium and long term study on adults with GH deficiency

      ea0070aep572
    • The SAGIT instrument: Potential utility in treatment decision-making in acromegaly

      ea0070aep573
    • Cushing’s disease: Assessment of MGMT expression in pituitary corticotroph tumors and its relationship to clinical, pathological and ultrastructural parameters

      ea0070aep574
    • Temporal trends in craniopharyngioma management and long term endocrine outcomes

      ea0070aep575
    • Sustained response to treatment with oral octreotide capsules: Results from the phase 3, randomized, double blind, placebo-controlled optimal study

      ea0070aep576
    • Biochemical control of most patients reverting to injectable long-acting somatostatin receptor ligands is achieved after one dose: Results from the phase 3, randomized, double blind, placebo-controlled optimal study

      ea0070aep577
    • Association between sagittal spine imbalance and radiological vertebral fractures in acromegaly: Does it reflect a pathophysiological link?

      ea0070aep578
    • Once-weekly somapacitan in japanese adults with growth hormone deficiency was well tolerated, with similar efficacy to daily growth hormone: A randomised trial

      ea0070aep579
    • Real life efficiency of pegvisomant therapy in acromegaly

      ea0070aep580
    • Sheehan like syndrome in males: A case series of three patients developing pituitary infarction following hypotension

      ea0070aep581
    • An asynchronous double growth hormone secreting pituitary adenoma ofa different proliferative potential – a case report

      ea0070aep582
    • Not just another headache – a rare case of recurrent pituitary collection

      ea0070aep583
    • A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in PRL- and ACTH-secreting pituitary tumoral cells: The role of cAMP/PKA-induced filamin A (FLNA) phosphorylation in the control of responsiveness to DRD2 agonist

      ea0070aep584
    • Kisspeptin-54 accurately identifies hypothalamic dysfunction in men with congenital hypogonadotropic hypogonadism

      ea0070aep585
    • Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-β-induced toxicity

      ea0070aep586
    • Pancreatic neuroendocrine tumour with suspected extrarenal secretion of 1,25-dihydroxyvitamin D3

      ea0070aep587
    • New advances in the diagnosis of gonadotroph tumours

      ea0070aep588
    • The cushing’s collaborative patient survey results

      ea0070aep589
    • High-dose corticosteroid treatment of immunotherapy-induced hypophysitis: A multi-centric, restrospective analysis

      ea0070aep590
    • Assessment of hypercoagulability in patients with cushing syndrome before and after surgical cure

      ea0070aep591
    • Morphometric vertebral fractures are highly prevalent in patients with non-functioning pituitary adenoma and related to older age and hypopituitarism

      ea0070aep592
    • Course of serum potassium levels during the hypertonic saline infusion test for diagnosis of diabetes insipidus

      ea0070aep593
    • Concordant testing results in differential diagnosis in ACTH-dependent cushing’s syndrome: A retrospective study of high dose dexamethasone suppression test (HDDST) and DDAVP stimulation test

      ea0070aep594
    • Gallium-68 -DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas

      ea0070aep595
    • Efficacy and safety of long-acting pasireotide (LA-PAS) in patients with uncontrolled acromegaly: Results from the prospective cohort of european observational acronis study

      ea0070aep596
    • High usage of drugs for neuropsychiatric morbidity in patients with Cushing´s disease before diagnosis and at 5–10 years follow-up – a nationwide study

      ea0070aep597
    • The importance of DHEA-S levels in cushing’s syndrome; is there a cut-off value in the differential diagnosis?

      ea0070aep598
    • Midparental height is an important predictive parameter in a late diagnosis of acromegaly and gigantism in adults. Single centre, pilot study

      ea0070aep599
    • Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations

      ea0070aep600
    • A case of wolfram syndrome with primary hypogonadism

      ea0070aep601
    • Effect of silibinin on acth synthesis and secretion in human adenomatous corticotropes in vitro

      ea0070aep602
    • TGF-β increases caspase 3 activation and migration in bronchial carcinoids

      ea0070aep603
    • Salivary cortisol and cortisone – Effects of liquorice and blood contamination

      ea0070aep604
    • An education programme for patients with pituitary tumours and their relatives; preliminary results

      ea0070aep605
    • Clinical picture and MRI findings in patients with hypophysitis – a single-centre experience

      ea0070aep606
    • Data mining analyses for precision medicine in acromegaly

      ea0070aep607
    • Metabolism of glucose in patients with acromegaly treated with Pegvisomant and/or Pasireotide LAR after resistance to first generation somatostatin receptor ligands

      ea0070aep608
    • Biliary stone disease in acromegaly under somatostatinanalogues: A longterm safety study

      ea0070aep609
    • Importance of sexual function assessment in multidimensional evaluation of AGHD patients: Baseline results from the management of adult growth hormone deficiency (MAGHD) study

      ea0070aep610
    • Effects of different therapeutic approaches on cardiovascular risk in patients with acromegaly: Results of a multicentric study

      ea0070aep611
    • IGF-I variability and its association with demographic and clinical characteristics in patients with acromegaly treated with injectable somatostatin receptor ligands (SRLs); results from OPTIMAL, an international prospective phase 3 study

      ea0070aep612
    • Analysis of adverse events in adult patients with acromegaly receiving oral octreotide capsules: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

      ea0070aep613
    • The effects of silent pituitary adenomas on pregnancy

      ea0070aep614
    • Cushing’s syndrome negatively affects socio-economic variables many years before the diagnosis: A nationwide registry-based cohort study

      ea0070aep615
    • Prevalence, predictors and outcomes of acute, life-threatening and perioperative complications in cushing’s syndrome

      ea0070aep616
    • SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

      ea0070aep617
    • Efficacy, safety and pitfalls of glucocorticoid therapy for patients with autoimmune hypophysitis

      ea0070aep618
    • Observational study of aetiology, efficacy of treatment and outcomes of hyponatraemia following pituitary surgery in a major neurosurgical centre

      ea0070aep619
    • Growth hormone deficiency in childhood acute lymphoblastic leukemia survivors – should systematic stimulation test be performed in all irradiated children?

      ea0070aep620
    • 9-CIS retinoic acid decreases pomc expression and cell viability in experimental model of ectopic cushing syndrome

      ea0070aep621
    • Sporadic neuroendocrine neoplasms in young-adult patients: Differences in natural history, prognosis and treatment compared to adult-elderly patients

      ea0070aep622
    • Temporal trends in incidence, evaluation and management of neuroendocrine neoplasms of the appendix-15 years’ experience

      ea0070aep623
    • Contribution of NGS in the genetic analysis of neuroendocrine tumors associated with Multiple Endocrine neoplasia type 1 (MEN 1)

      ea0070aep624
    • Malignant insulinoma treated with ¹⁷⁷Lu-DOTATATE: Results in the first year post-therapy

      ea0070aep625
    • Surgical and survival outcomes of early peptide receptor radionuclide therapy for downstaging locally advanced or oligometastatic pancreatic neuroendocrine neoplasms

      ea0070aep626
    • Absolute oral bioavailability and absorption, metabolism, excretion of [14C]-Labeled paltusotine (CRN00808), an orally bioavailable, nonpeptide, selective, somatostatin receptor 2 (sst2) biased agonist for the treatment of acromegaly

      ea0070aep627
    • Safety and IGF-1 levels with once daily oral sst2 agonist paltusotine (CRN00808) in acromegaly patients previously treated with peptide long-acting somatostatin receptor ligands: Initial data from the open label ACROBAT Edge phase 2 study

      ea0070aep628
    • The time, mode and markers of pituitary function deterioration in patients with PROP1 mutation. Single centre, longitudinal observation

      ea0070aep629
    • Clinical presentations of patients with MEN 1 syndrome and its phenocopies

      ea0070aep630
    • Functional panhypopituitarism of anorexia

      ea0070aep631
    • A case of primary hypophysitis with cavernous sinus infiltration causing an unilateral internal carotid artery occlusion

      ea0070aep632
    • ACTH-secreting pituitary tumor with delayed aggressive clinical recurrence – management challenges

      ea0070aep633
    • Unusual case of women suffering from aggressive silent thyrotropinoma treated with somatostatin analogues during pregnancy

      ea0070aep634
    • Secondary amenorrhea, acute hydrocephalus and syndrome of inappropriate secretion of antidiuretic hormone as first manifestations of neurosarcoidosis

      ea0070aep635
    • Complicated endocrinopathy after liver transplantation for unusual diagnosis

      ea0070aep636
    • A rare association of hypogonadotropic hypogonadism and GH deficiency in a patient with Addison’s disease

      ea0070aep637
    • 46XY DSD as initial clinical presentation in a patient with syndromic combined pituitary hormones deficiency

      ea0070aep638
    • Clinical and hormonal features of congenital hypopituitarism

      ea0070aep639
    • Looking for cyclic cushing’s syndrome

      ea0070aep640
    • Medical treatment leading to remission of ectopic cushing’s syndrome

      ea0070aep641
    • An uncommon cause of atrial fibrillation

      ea0070aep642
    • Osmotic demyelination syndrome in a patient with noonan syndrome and anterior hypopituitarism

      ea0070aep643
    • A case of developmental delay by 18q23 deletion syndrome

      ea0070aep644
    • Sodium copeptin ratio differentiates patients with and without acute diabetes insipidus post neurosurgery

      ea0070aep645
    • Differences in acquired and idiopathic adult-onset growth hormone deficiency

      ea0070aep646
    • Evaluation of the of alpha2-adrenergic receptors stimulation effect on copeptin secretion, based on the result of the test with clonidine used in the diagnosis of children with short stature

      ea0070aep647
    • Typical carcinoid of the nose: The role of somatostatin agonist following surgery

      ea0070aep648
    • Multi-hormonal secretion in a young male with a large cystic pancreatic neuroendocrine neoplasm

      ea0070aep649
    • Differentiation of Insulinoma from accessory spleen by 99mTc-labelled heat-denaturated red blood cell scintigraphy

      ea0070aep650
    • Predictors of Cushing’s disease remission after transsphenoidal endoscopic surgery

      ea0070aep651
    • Acrodat – a useful tool to manage acromegaly patients

      ea0070aep652
    • Characterization of pituitary adenomas by immunohistochemistry of pituitary-specific transcription factors and their correlation with hormonal subtypes

      ea0070aep653
    • Our experience with lu-dotatate in patients with neuroendocrine tumors in a tertiary hospital

      ea0070aep654
    • Characteristics of severe forms of Cushing’s disease compared to milder cases

      ea0070aep656
    • The impact of variations in laboratory measurements of IGF-1 and random growth hormone on the classification of acromegaly disease activity status: Lessons from the UK Acromegaly Register Reference Laboratory

      ea0070aep657
    • Prevalence of non-alcoholic fatty liver disease in patients with Cushing disease (CD)

      ea0070aep658
    • Tumour progression in clinically non-functioning pituitary adenomas- does somatostatin analogue therapy decrease the risk?

      ea0070aep659
    • Predictors for remission after transsphenoidal surgery in acromegaly: A dutch multicenter study

      ea0070aep660
    • Metyrapone treatment in endogenous Cushing’s syndrome. Results from a prospective multicenter, open-label, phase III/IV study: Prompt

      ea0070aep661
    • Predictors of response to medical therapy with pegvisomant and pasireotide lar in SRLs-resistant acromegaly

      ea0070aep662
    • Efficacy of monotherapy versus combined GH receptor antagonist therapy in patients with somatostatin receptor analogues resistant acromegaly

      ea0070aep663
    • The role of repeated prolactin samples in patients with hyperprolactinaemia

      ea0070aep664
    • Assessment of disease control in patients with acromegaly treated with long-acting somatostatin analogs (SMSa) varies according to the time when IGF-I levels are measured during the month following the injection

      ea0070aep665
    • Surgical and clinical outcome in elderly patients affected by non-functional pituitary adenoma treated by endoscopic transnasal transsphenoidal surgery: A monocentric study

      ea0070aep666
    • Gender differences in airway obstruction in men and women with acromegaly: A longitudinal study

      ea0070aep667
    • Withdrawal from long-acting somatostatin receptor ligand injections in adult patients with acromegaly: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

      ea0070aep668
    • Impact of imputation method on efficacy results from the phase 3 optimal study of oral octreotide capsules in adult patients with acromegaly

      ea0070aep669
    • Eucaloric very low-carbohydrate ketogenic diet as a new supportive treatment modality for acromegaly?

      ea0070aep670
    • To score or not to score? Is Ki-67 analysis worthwhile in pituitary neuroendocrine tumours?

      ea0070aep671
    • Giant prolactinomas: Is it possible to stop treatment?

      ea0070aep672
    • Development of a local reference range for hypertonic saline-stimulated copeptin

      ea0070aep673
    • A key role for conservative treatment in the management of pituitary apoplexy

      ea0070aep674
    • Gender dimorphism of intramuscular fatty infiltration and related muscle dysfunction in patients with long-term control of acromegaly

      ea0070aep675
    • European Society of Endocrinology audit and multi-country comparison of Adult Growth Hormone Deficiency (AGHD) treatment in clinical practice in Europe and Australia; –how closely are protocols and best practice recommendations followed

      ea0070aep676
    • Carpal tunnel syndrome is common in patients with undiagnosed acromegaly – a swedish nationwide study

      ea0070aep677
    • Levoketoconazole in the treatment of endogenous Cushing’s syndrome: Extended evaluation phase results of the SONICS study

      ea0070aep678
    • Role of NGS in the diagnostic work-up of pituitary tumors and ‘incidental findings’

      ea0070aep679
    • fMRI for cognitive evaluation of adult survivors of childhood craniopharyngioma

      ea0070aep680
    • Effects of long-term growth hormone replacemente therapy on body composition in adult patients with growth hormone deficiency

      ea0070aep681
    • Perception of stature and quality of life in young adult men referred for tall stature during adolescence. Perception of stature and quality of life in young adult men referred for tall stature during adolescence.

      ea0070aep682
    • Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH- and GH-secreting pituitary neuroendocrine tumor cell lines

      ea0070aep683
    • Evaluation of somatostatin and dopamine receptor expression in nonfunctioning pituitary adenomas

      ea0070aep684
    • High prevalence of pituitary deficiency after cranial radiation therapy for skull base meningioma: The importance of an annual screening.

      ea0070aep685
    • Role of 68ga-dotatoc pet/ct in the management of neuroendocrine tumors

      ea0070aep686
    • Endoscopic transsphenoidal pituitary surgery (ETPS) for pituitary tumors: Outcomes and complications

      ea0070aep687
    • Do cardiovascular risk factors predispose to pituitary apoplexy?

      ea0070aep688
    • Trabecular bone score as a useful tool for assessment of fracture risk in acromegaly

      ea0070aep689
    • Metabolic abnormalities in patients with childhood onset of hypopituitarism – single center,long term observation

      ea0070aep690
    • Early basal growth hormone level and nadir growth hormone level in oral glucose tolerance test as predictors for surgical cure in acromegaly

      ea0070aep691
    • Quantitative bone assessment by radiofrequency echographic multi-spectrometry (REMS) in patients with acromegaly – a preliminary study

      ea0070aep692
    • Analysis of the value of bilateral inferior petrosal sinus sampling in the diagnosis and treatment of Cushing’s disease in patients with a negative or inconclusive result of magnetic resonance imaging

      ea0070aep693
    • Micromegaly or acromegaly? A retrospective longitudinal study on clinical aspects and comorbidities in a large cohort of patients referred to a single tertiary center

      ea0070aep694
    • Markers of recurrence in cushing’s disease: The role of post-operative serum cortisol and desmopressin test

      ea0070aep695
    • Long-term response to cabergoline treatment in men with macroprolactinoma is independent of tumor size

      ea0070aep696
    • Abstract unavailable

      ea0070aep697
    • Inferior petrosal sinus sampling – 16 years of experience from a single tertiary center in Israel

      ea0070aep698
    • Determinants of epicardial fat in patients with acromegaly

      ea0070aep699
    • Disconnection hyperprolactinaemia and its correlation with tumour size: A study of 210 patients with histologically proven non-functioning pituitary macroadenomas

      ea0070aep700
    • Role of 1 mg ACTH Stimulation Test to predict adrenocortical reserve and need of glucocorticoid therapy in non-functioning pituitary adenomas undergoing surgery

      ea0070aep701
    • Gigantism associated with hyperprolactinemia due to a pituitary macroadenoma in an adolescent girl

      ea0070aep702
    • Cabergoline resistance in a patient with prolactinoma with debut before puberty

      ea0070aep703
    • A rare etiology of hyperprolactinemia: Factitious hypoglycemia

      ea0070aep704
    • Pituitary gland metastasis of endometrial cancer: A case report

      ea0070aep705
    • Microprolactinoma, PCOS Or stress induced hyperprolactinemia? – case report

      ea0070aep706
    • A prolactinoma of rare localization as part of familial isolated pituitary adenomas

      ea0070aep707
    • A rare coexistence of acromegaly, myasthenia gravis, sicca syndrome, and elevated serum IgG4 levels: A single case report

      ea0070aep708
    • A case of cyclic cushing’s disease – cortisol surfing; catching the cortisol wave!

      ea0070aep709
    • Successful pregnancy in a woman with acromegaly treated with lanreotide

      ea0070aep710
    • Isolated adrenocorticotropic hormone deficiency in a female with ectopic posterior hypophysis

      ea0070aep711
    • Thickening of the pituitary stalk: About 4 cases

      ea0070aep712
    • Pregnancy and pituitary adenomas: A case series

      ea0070aep713
    • Short stature in turner syndrome: Should we assess growth hormone secretion?

      ea0070aep714
    • Case of differential diagnosis in a patient presenting with paroxysmal arterial hypertension

      ea0070aep715
    • A rare case of panhypopituitarism caused by TNF-α inhibitors

      ea0070aep716
    • Natural course of incidentally found nonfunctioning pituitary macroadenoma

      ea0070aep717
    • Evaluation of early predictors of metabolic syndrome in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET)

      ea0070aep718
    • Experience in complex therapy of selective and non-selective dopamine agonists in women with resistant prolactinomas for recovering of ovulation function

      ea0070aep719
    • An analysis of craniopharyngioma patients in malta: Epidemiology, patient characterisation and long-term sequelae

      ea0070aep720
    • Septo-optic dysplasia with late-onset diagnosis: An uncommon presentation of a rare disease

      ea0070aep721
    • Doses of tolvaptan needed in chronic therapy of SIADH-induced euvolemic hyponatremia vary according to the etiology of SIADH

      ea0070aep722
    • Soluble alpha klotho measurement: Comparison of measurements by different commercially available assays in healthy subjects and active acromegaly

      ea0070aep723
    • Metformin and everolimus: A promising combination for neuroendocrine tumors treatment

      ea0070aep724
    • One year of growth hormone therapy in spanish adults with prader-willi syndrome (PWS) improves body composition without changes in bone mineral density

      ea0070aep725
    • Efficacy and safety of urea in syndrome of inappropriate secretion of antidiuretic hormone on a secondary hospital

      ea0070aep726
    • Multiple metastatic NET of unknown primary site in a young patient with carcinoid syndrome: Can we treat it as a gastrointestinal NET?

      ea0070aep727
    • A relationship between motilin and ghrelin in human motilin receptor transgenic mice

      ea0070aep728
    • Characterization of epithelial-mesenchymal transition in growth hormone-secreting adenomas

      ea0070aep729
    • Global methylation-demethylation status in pituitary neuroendocrine tumors as potential therapeutic target

      ea0070aep730
    • The expression of oxytocin receptor (OXTR) in metastatic pancreatic neuroendocrine tumors (PNETs)

      ea0070aep731
    • Metastatic insulinoma managed with lutetium (177LU) and somatostatin analog

      ea0070aep732
    • Tobacco smoke induces aberrant pulmonary neuroendocrine differentiation via different MAPK pathways

      ea0070aep733
    • Use of tolvaptan in acute post-surgical hyponatremia in patients with pituitary diseases

      ea0070aep734
    • Metabolic status of patients with combined pituitary hormone deficiency due to PROP1 mutation

      ea0070aep735
    • Kisspeptin levels in children and adolescents

      ea0070aep736
    • Body composition and bone mineral density in 107 patients with childhood onset growth hormone deficiency (CO-GHD) at the time of transition from pediatric to adulthood endocrine care

      ea0070aep737
    • Management of pregnant women with prolactinomas and analysis of their pregnancy outcomes

      ea0070aep738
    • Interleukin-6 response to insulin-induced hypoglycemia is associated with hypothalamic-pituitary-adrenal axis activation

      ea0070aep739
    • The effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments

      ea0070aep740
    • Cushing’s syndrome in the 21st century, not what it used to be: A single institution experience

      ea0070aep741
    • Visual impairment in patients with pituitary apoplexy

      ea0070aep742
    • Central hypothyroidism as an adverse effect of bexarotene treatment for cutaneous T-cell lymphoma

      ea0070aep743
    • Pasireotide-induced hyperglycemia and efficacy of antidiabetic treatments in patients with acromegaly: Evaluation of two referral centers

      ea0070aep744
    • The characteristic of patients with pituitary stalk lesions – single center,long term observation

      ea0070aep745
    • Preoperative pegvisomant as a potential therapeutic option to improve cardiac function in Acromegaly-induced cardiomyopathy: Two cases

      ea0070aep746
    • A prospective, non-interventional, observational, multi-center study of quality of life in people with acromegaly receiving lanreotide autogel

      ea0070aep747
    • Soluble klotho: A possible predictor of quality of life in acromegaly patients

      ea0070aep748
    • Pregnancy outcomes in women receiving growth hormone therapy enrolled in NordiNet international outcome study (IOS) and American Norditropin Studies: Web Enabled Research (ANSWER Program)

      ea0070aep749
    • Country-specific differences in adult growth hormone deficiency diagnosis and treatment rates

      ea0070aep750
    • Evaluation of haemolitic complement activity (ch50) and igg subclasses in adult growth hormone deficiency: Preliminary data

      ea0070aep751
    • FDG PET contribution to ectopic prolactinoma diagnosis - case report

      ea0070aep752
    • SF-12 or SF-36 in pituitary disease? towards concise patient-reported outcomes measurements

      ea0070aep753
    • The role of surgery in the treatment of craniopharyngioma: A comparison of the transsphenoidal approach and the interbasal hemisphere approach based on surgical outcomes

      ea0070aep754
    • An analysis of incidence and characteristics of cushing’s syndrome in malta: A population based study

      ea0070aep755
    • Patients receiving a range of doses of prior injectable somatostatin receptor ligands respond to oral octreotide in the treatment of acromegaly: Results from the phase 3 optimal study

      ea0070aep756
    • AIP gene germline mutations in non-selected patients with sporadic pituitary macrodenomas

      ea0070aep757
    • Silent corticotroph adenoma: Experience with six cases

      ea0070aep758
    • MRI follow-up of patients with acromegaly treated with first-generation somatostatin analogues (SMSa): Is there a difference during primary or post-operative treatment?

      ea0070aep759
    • Associations of endocrine and metabolic complications of childhood- and adult-onset craniopharingeoma with the histological subtype

      ea0070aep760
    • The united russian registry on patients with acromegaly

      ea0070aep761
    • Immunohistochemical subtypes of growth hormone-secreted pituitary adenoma and relationship with the clinical course and seconder malignancy

      ea0070aep762
    • Prolactinoma In childhood and adolescence – a systematic review and meta-analysis

      ea0070aep763
    • Combined pitutitary hormone deficiency in a patient with charge syndrome

      ea0070aep764
    • Controversies in the spectrum of GH-IGF-I axis disorders requiring replacement therapy

      ea0070aep765
    • Severe heart failure in a young male patient with unrecognized hypopituitarism consequent to hemorrhagic fever with renal syndrome and undiagnosed hemochromatosis

      ea0070aep766
    • Severe hyponatremia revealing hypopituitarism of undetermined etiology

      ea0070aep767
    • A case of isolated ACTH deficiency and autoimmune pancreatitis associated with pembrolizumab treatment

      ea0070aep768
    • Empty sella: Who thinks of it while studying hyponatremia?

      ea0070aep769
    • Massive pulmonary embolism in a newly diagnosed acromegaly patient

      ea0070aep770
    • Persistent hypercortisolism due to cushing disease

      ea0070aep771
    • The effect of chronic glucocorticoid exposure on brown adipose tissue in patients with cushing’s disease

      ea0070aep772
    • A rare outcome after surgical removal of insulinoma- case presentation

      ea0070aep773
    • Evaluation of factors associated with presence and growth of thyroid nodules in patients with acromegaly

      ea0070aep774
    • FSH levels are related to E-cadherin expression and subcellular location in non-functioning pituitary neuroendocrine tumours

      ea0070aep775
    • To optimize the acute octreotide suppression test in predicting the efficacy of long acting somatostatin analogues in acromegaly

      ea0070aep776
    • Acromegaly is associated with reduced socioeconomic status and more so in female patients: A nationwide population-based study

      ea0070aep777
  • Reproductive and Developmental Endocrinology
  • • Case-control study on ACE2 expression in children with short stature

      ea0070aep778
    • Coagulation abnormalities in patients with klinefelter syndrome compared to age-matched healthy controls: Cross-sectional assessment by thrombin generation test

      ea0070aep779
    • Radioidine (RAI) as a new therapy for the treatment of ovarian cancer through the sodium/iodide symporter (NIS)

      ea0070aep780
    • Luteinizing hormone/choriogonadotropin receptor (LHCGR) mediates different kinetics of G proteins, β-arrestins and cAMP activation

      ea0070aep781
    • New data in turner syndrome: Results from a long-term prospective observational study from diagnosis to adulthood

      ea0070aep782
    • Establishing an anti-müllerian hormone (AMH) cut-off to determine polycystic ovarian morphology (PCOM) supporting diagnosis of polycystic ovarian syndrome (PCOS): The APHRODITE study

      ea0070aep783
    • Polycystic ovary syndrome is burdened with a high comorbidity rate and medication use independent of BMI: A longitudinal community based study

      ea0070aep784
    • Structural analysis of the impact of a novel androgen receptor gene mutation in two adult patients with mild androgen insensitivity syndrome

      ea0070aep785
    • Endogenous doping: Physical exercise acutely increases testosterone levels. Results from a meta-analysis

      ea0070aep786
    • Clinical and genetic characterization of two cases of central hypogonadism in Klinefelter syndrome

      ea0070aep787
    • Clinical and genetic overlap between congenital hypogonadotropic hypogonadism and cornelia de lange syndrome

      ea0070aep788
    • X-Linked Adrenoleukodystrophy: Report of an atypical case

      ea0070aep789
    • Clinical evaluation and genetic analysis of patients affected by premature ovarian insufficiency: Identification and characterization of a new mutation of the BMP-15

      ea0070aep790
    • A case of Swyer syndrome with successful extirpation of gonadal tissues in 70 years old women

      ea0070aep791
    • Ovarian mucinous cystadenoma presenting with virilization

      ea0070aep792